WO2025220580A1 - Hydrogenophilus bacterium mutant having improved crotonyl-coa production capability - Google Patents
Hydrogenophilus bacterium mutant having improved crotonyl-coa production capabilityInfo
- Publication number
- WO2025220580A1 WO2025220580A1 PCT/JP2025/014249 JP2025014249W WO2025220580A1 WO 2025220580 A1 WO2025220580 A1 WO 2025220580A1 JP 2025014249 W JP2025014249 W JP 2025014249W WO 2025220580 A1 WO2025220580 A1 WO 2025220580A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- seq
- coa
- polypeptide
- gene
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
Definitions
- the present invention relates to a mutant Hydrogenophilus bacterium that has improved crotonyl-CoA production ability, thereby improving its ability to produce various useful substances produced by its metabolism.
- Japan aims to reduce its greenhouse gas emissions, including carbon dioxide and methane, by 46% by 2030 compared to 2013 levels.
- gases such as carbon dioxide, methane, and carbon monoxide are attracting attention as more sustainable carbon feedstocks, and there is growing interest in technologies that use microorganisms to utilize these gases to produce valuable chemicals and biofuels. In particular, there are high hopes for fixing and effectively utilizing carbon dioxide, which contributes significantly to global warming.
- Examples of useful chemicals produced via crotonyl CoA include crotyl alcohol, butadiene, and butanol.
- Butadiene is used as a raw material for synthetic rubbers such as butadiene rubber, styrene-butadiene rubber, acrylonitrile-butadiene rubber, and chloroprene rubber, and synthetic resins such as styrene-butadiene-acrylonitrile (ABS) resin and styrene-butadiene methacrylate (MBS) resin. It is also used as a raw material for other chemical products such as adiponitrile, 1,4-butanediol, cyclododecatriene, chloroprene, and sulfolane.
- synthetic rubbers such as butadiene rubber, styrene-butadiene rubber, acrylonitrile-butadiene rubber, and chloroprene rubber
- synthetic resins such as styrene-butadiene-acrylonitrile (ABS) resin and styrene-butadiene methacrylate (MBS
- Butanol is an organic chemical raw material with a wide range of applications in industrial sectors such as the chemical, pharmaceutical, and petroleum industries. It is used to manufacture acrylic and methacrylic acid esters, which are used in the production of coatings, plastics, textiles, and adhesives; glycol ethers, which are used in the production of coatings and electronic products; butyl acetate, which is used in the production of paints, inks, coatings, and synthetic fruit fragrances; butylamine, which is used in the production of pesticides and pharmaceuticals; and amine resins. Butanol also has direct uses as a solvent in inks and dyes, extraction solvent, antifreeze fluid, cosmetic ingredient, and chromatography eluent component.
- butanol which has four carbon atoms, has many advantages over ethanol, which has two carbon atoms: it is more fuel efficient, it can be easily mixed with gasoline or diesel oil, and it has low corrosiveness and low water content. Therefore, it is attracting attention as a next-generation biofuel to follow bioethanol.
- butanol is produced using aerobic bacteria or facultative anaerobic bacteria, which grow relatively quickly.
- Clostridium bacteria which are obligate anaerobes, have a metabolic pathway shown in Figure 2 that produces butanol from glucose via pyruvate, acetyl-CoA, crotonyl-CoA, and butyryl-CoA.
- this metabolic pathway it is possible to construct a metabolic pathway from pyruvate to butyryl-CoA and then to butanol in bacteria that do not naturally produce butanol.
- Non-Patent Document 1 in aerobic bacteria and facultative anaerobic bacteria, the reduction reaction of enoyl-CoA via fatty acid synthesis, fatty acid beta-oxidation pathways, etc., is ubiquitous in the reaction of crotonyl-CoA to butyryl-CoA, and therefore it is theoretically possible to produce butyryl-CoA from glucose.
- aerobic bacteria and facultative anaerobic bacteria cannot actually produce butyryl-CoA from butyryl-CoA.
- Hydrogen bacteria can grow using carbon dioxide as the sole carbon source, utilizing the chemical energy generated by the reaction of hydrogen and oxygen. This allows them to produce chemical products using a mixture of oxygen, hydrogen, and carbon dioxide as raw materials, enabling them to efficiently organicize carbon dioxide. They can also be cultured in simple media that do not contain organic substances such as sugars. Generally, hydrogen bacteria grow slowly, but among hydrogen bacteria, the Hydrogenophilus bacteria grow at an exceptionally fast rate. The Mitsubishi Research Institute Report No.
- the primary objective of the present invention is to provide a mutant Hydrogenophilus bacterium that has improved crotonyl-CoA production ability and can therefore be used for the efficient production of useful substances produced via crotonyl-CoA.
- Hydrogenophilus bacteria possess a metabolic pathway for producing crotonyl-CoA from pyruvate, as shown in Figure 1.
- Hydrogenophilus bacteria also possess a metabolic pathway for converting crotonyl-CoA to 3-hydroxybutyryl-CoA.
- this metabolic pathway is active, the production of the target product decreases when butadiene is produced from crotonyl-CoA via crotyl alcohol, or when butanol is produced from crotonyl-CoA via butyryl-CoA.
- the present inventors evaluated the enzyme activity of a strain in which HPTL_0565 (SEQ ID NO: 1) on the genome of Hydrogenophilus thermorteolus was disrupted and a wild-type strain before disruption, using crotonyl-CoA as a substrate in the cell lysate.
- HPTL_0565 SEQ ID NO: 1
- crotonyl-CoA had almost completely disappeared 1 minute after the start of the enzymatic reaction
- HPTL_0565-disrupted strain crotonyl-CoA remained even 30 minutes after the start of the enzymatic reaction (Figure 4).
- the present inventors also evaluated the enzyme activity of a strain in which HPTL_0565 (SEQ ID NO: 1) on the genome of Hydrogenophilus thermorteolus was disrupted and a wild-type strain before disruption, using 3-hydroxybutyryl-CoA from the cell lysate as a substrate.
- the strain in which HPTL_0565 was disrupted produced a higher amount of crotonyl-CoA than the wild-type strain ( Figure 5).
- [1] A Hydrogenophilus bacterium mutant in which one or more (at least one) of the enzyme genes present on the chromosome of the Hydrogenophilus bacterium, which catalyze any reaction in the pathway that produces 3-hydroxybutyryl-CoA from crotonyl-CoA, are disrupted: (a) A gene encoding a polypeptide having 3-hydroxybutyryl-CoA dehydratase activity (b) a gene encoding a polypeptide having enoyl-CoA hydratase activity (c) a gene encoding a polypeptide having 3-hydroxyacyl-CoA dehydrogenase activity (d) A gene encoding a polypeptide having methylglutaconyl-CoA hydratase activity [2] A mutant of [1] in which one or more of the genes (a) to (d) above have been disrupted by deletion of the entire region or
- Measures to curb the increase in carbon dioxide include reducing carbon dioxide emissions and fixing emitted carbon dioxide.
- energy sources such as solar, wind, and geothermal energy are being used in place of fossil fuels.
- the use of these types of energy sources has not been enough to sufficiently curb the increase in carbon dioxide. Therefore, it is necessary to promote the fixation or resource recovery of emitted carbon dioxide.
- Carbon dioxide can be fixed physically or chemically, but if it is fixed using living organisms, it can be used to produce organic matter that can be used as food, feed, fuel, etc., or as raw materials for chemical products. In other words, carbon dioxide itself can be directly converted into a valuable resource. This can solve two problems: global warming caused by increased carbon dioxide, and the difficulty in securing food, feed, fuel, and raw materials for chemical products.
- the mutant of the present invention is a Hydrogenophilus bacterium with an extremely high growth rate and therefore extremely high substance-producing capacity, in which the gene encoding an enzyme that catalyzes a side reaction pathway in the pathway for producing useful substances from crotonyl-CoA has been disrupted in its genome, and therefore, when used to produce useful substances such as crotyl alcohol, butadiene, and butanol, which are produced via crotonyl-CoA, the production efficiency can be improved.
- the mutant Hydrogenophilus bacterium of the present invention can solve the problem of global warming caused by increased carbon dioxide, while meeting the demand for the production of chemical products such as plastics, rubber, fibers, polymers, and biofuels.
- FIG. 1 shows a metabolic pathway in which Clostridium bacteria produce butanol from glucose via crotonyl-CoA.
- FIG. 1 shows a metabolic pathway for producing butanol from pyruvate that many microorganisms have. This is a chromatogram showing the results of reacting cell lysates of 14 strains of Escherichia coli, each of which had been introduced with genes presumed to be side reaction enzymes of the Hydrogenophilus thermorteolus TH-1 strain, with the substrate crotonyl-CoA for 10 minutes, and detecting 3-hydroxybutyryl-CoA and crotonyl-CoA at 5 and 10 minutes using high-performance liquid chromatography (HPLC).
- HPLC high-performance liquid chromatography
- HPLC high-performance liquid chromatography
- the Hydrogenophilus bacterium mutant of the present invention is a mutant in which one or more of the following genes (a) to (d) present on the chromosome of a Hydrogenophilus bacterium have been disrupted:
- the enzymes encoded by the following genes (a) to (d) produce 3-hydroxybutyryl-CoA from crotonyl-CoA, either alone or in combination with other enzymes: For each of genes (a) to (d), two or more genes with different structures may exist.
- genes (a) to (d) are disrupted includes, for example, cases where gene (a) and gene (b) are disrupted, and cases where multiple genes corresponding to gene (b) are disrupted.
- (c) A gene encoding a polypeptide having 3-hydroxyacyl-CoA dehydrogenase activity.
- examples of the genes in (c) include HPTL_0624 and HPTL_0998.
- (d) A gene encoding a polypeptide having methylglutaconyl-CoA hydratase activity. In Hydrogenophilus thermorteolus, an example of the gene (d) is HPTL_0272.
- Gene disruption refers to reducing the activity of the product of each gene to 50% or less of that of the parent strain before disruption. Preferably, it is 10% or less, and particularly 1% or less. This results in less production of 3-hydroxybutyryl-CoA from crotonyl-CoA than in the parent strain.
- the activity of the gene product is evaluated by measuring the activity of the enzyme it catalyzes. A decrease in gene expression leads to a decrease in the activity of the gene product. Gene expression levels can be measured using quantitative PCR (qPCR) or next-generation sequencing (NGS). Even if a gene's coding region or expression regulatory region is partially mutated, the gene may still be expressed normally.
- Gene disruption can be achieved by mutating (by base deletion, substitution, insertion, addition, or a combination thereof) the coding region or gene expression regulatory region, such as the promoter region, of the gene on the chromosome of a Hydrogenophilus bacterium. Methods for gene disruption are well known, including gene knockout using homologous recombination and phenotype-based screening using random gene mutations introduced using mutagens.
- the mutant of the present invention preferably has a mutation in one or more of the above-mentioned genes (a) to (d), which are coding regions.
- Mutation of each coding region typically involves deleting all or part of each gene.
- a gene can be disrupted by inserting a nucleotide, oligonucleotide, or polynucleotide into the gene.
- all or part of each gene can be replaced with another nucleotide, oligonucleotide, or polynucleotide.
- multiple nucleotide deletions, substitutions, and/or insertions may be introduced at a single location within the gene, or may be distributed across multiple locations.
- the number of nucleotides to be deleted, substituted, or inserted is preferably 3 or more. It is also preferable to delete, replace, or insert nucleotides that account for 1% or more of the entire length of the gene. This ensures that each gene is disrupted reliably. It is also possible to delete or replace the entire length of each gene (i.e., 100% of the nucleotides constituting each gene).
- the number of nucleotides to be inserted can be 100,000 or less.
- Examples of the above-mentioned (a) gene of a bacterium of the genus Hydrogenophilus include the following genes (a1) to (a5): (a1) DNA containing (particularly consisting of) the base sequence of SEQ ID NO: 1 (a2) DNA containing (particularly consisting of) a nucleotide sequence having 90% or more, particularly 95% or more, particularly 98% or more, particularly 99% or more identity to the nucleotide sequence of SEQ ID NO: 1, and encoding a polypeptide having 3-hydroxybutyryl-CoA dehydratase activity.
- DNA encoding a polypeptide comprising (particularly consisting of) the amino acid sequence of SEQ ID NO: 2 (a4) DNA encoding a polypeptide comprising (particularly consisting of) an amino acid sequence having 90% or more, particularly 95% or more, particularly 98% or more, particularly 99% or more identity to SEQ ID NO: 2 and having 3-hydroxybutyryl-CoA dehydratase activity. (a5) DNA encoding a polypeptide comprising (particularly consisting of) an amino acid sequence in which 1 to 10, preferably 1 to 5, preferably 1 to 3, preferably 1 amino acid in the amino acid sequence of SEQ ID NO: 2 have been deleted, substituted, inserted, or added, and which has 3-hydroxybutyryl-CoA dehydratase activity.
- SEQ ID NO: 1 is the nucleotide sequence of HPTL_0565, a gene of the Hydrogenophilus thermorteolus wild strain
- SEQ ID NO: 2 is the amino acid sequence of a polypeptide encoded by HPTL_0565 of the Hydrogenophilus thermorteolus wild strain.
- Examples of the above-mentioned (b) gene of bacteria of the genus Hydrogenophilus include the following genes (b1) to (b5): (b1) DNA containing (particularly consisting of) the base sequence of SEQ ID NO: 3 (b2) DNA containing (particularly consisting of) a nucleotide sequence having 90% or more, particularly 95% or more, particularly 98% or more, particularly 99% or more identity to the nucleotide sequence of SEQ ID NO: 3, and encoding a polypeptide having enoyl-CoA hydratase activity.
- DNA encoding a polypeptide comprising (particularly consisting of) the amino acid sequence of SEQ ID NO: 4 (b4) DNA encoding a polypeptide consisting of an amino acid sequence having 90% or more, particularly 95% or more, particularly 98% or more, particularly 99% or more identity to SEQ ID NO: 4 and having enoyl-CoA hydratase activity.
- SEQ ID NO: 3 is the nucleotide sequence of HPTL_1099, a gene of the Hydrogenophilus thermorteolus wild strain
- SEQ ID NO: 4 is the amino acid sequence of a polypeptide encoded by HPTL_1099 of the Hydrogenophilus thermorteolus wild strain.
- Examples of the above-mentioned (b) gene of bacteria of the genus Hydrogenophilus also include the following genes (b6) to (b10): (b6) DNA comprising (particularly consisting of) the base sequence of SEQ ID NO: 5 (b7) DNA comprising (particularly consisting of) a nucleotide sequence having 90% or more, particularly 95% or more, particularly 98% or more, particularly 99% or more identity to the nucleotide sequence of SEQ ID NO: 5, and encoding a polypeptide having enoyl-CoA hydratase activity.
- DNA encoding a polypeptide comprising (particularly consisting of) the amino acid sequence of SEQ ID NO: 6 (b9) DNA encoding a polypeptide comprising (particularly consisting of) an amino acid sequence having 90% or more, particularly 95% or more, particularly 98% or more, particularly 99% or more identity to SEQ ID NO: 6 and having enoyl-CoA hydratase activity.
- (b10) DNA encoding a polypeptide comprising (particularly consisting of) an amino acid sequence in which 1 to 20, preferably 1 to 10, preferably 1 to 5, preferably 1 to 3, preferably 1 amino acid in the amino acid sequence of SEQ ID NO: 6 have been deleted, substituted, inserted, or added, and which has enoyl-CoA hydratase activity.
- SEQ ID NO: 5 is the nucleotide sequence of HPTL_1333, a gene of the Hydrogenophilus thermorteolus wild strain
- SEQ ID NO: 6 is the amino acid sequence of a polypeptide encoded by HPTL_1333 of the Hydrogenophilus thermorteolus wild strain.
- Examples of the above-mentioned (c) gene of a bacterium of the genus Hydrogenophilus include the following genes (c1) to (c5): (c1) DNA comprising (particularly consisting of) the base sequence of SEQ ID NO: 7 (c2) DNA containing (particularly consisting of) a nucleotide sequence having 90% or more, particularly 95% or more, particularly 98% or more, particularly 99% or more identity to the nucleotide sequence of SEQ ID NO: 7, and encoding a polypeptide having 3-hydroxyacyl-CoA dehydrogenase activity.
- DNA encoding a polypeptide comprising (particularly consisting of) the amino acid sequence of SEQ ID NO: 8 (c4) DNA encoding a polypeptide comprising (particularly consisting of) an amino acid sequence having 90% or more, particularly 95% or more, particularly 98% or more, particularly 99% or more identity to SEQ ID NO: 8 and having 3-hydroxyacyl-CoA dehydrogenase activity.
- (c5) DNA encoding a polypeptide comprising (particularly consisting of) an amino acid sequence in which 1 to 20, preferably 1 to 10, preferably 1 to 5, preferably 1 to 3, preferably 1 amino acid in the amino acid sequence of SEQ ID NO: 8 have been deleted, substituted, inserted, or added, and which has 3-hydroxyacyl-CoA dehydrogenase activity.
- SEQ ID NO: 7 is the nucleotide sequence of HPTL_0624, a gene of the Hydrogenophilus thermorteolus wild strain
- SEQ ID NO: 8 is the amino acid sequence of the polypeptide encoded by HPTL_0624 of the Hydrogenophilus thermorteolus wild strain.
- Examples of the above-mentioned (c) gene of bacteria of the genus Hydrogenophilus also include the following genes (c6) to (c10): (c6) DNA comprising (particularly consisting of) the base sequence of SEQ ID NO: 9 (c7) DNA containing (particularly consisting of) a nucleotide sequence having 90% or more, particularly 95% or more, particularly 98% or more, particularly 99% or more identity to the nucleotide sequence of SEQ ID NO: 9, and encoding a polypeptide having 3-hydroxyacyl-CoA dehydrogenase activity.
- DNA encoding a polypeptide comprising (particularly consisting of) the amino acid sequence of SEQ ID NO: 10 (c9) DNA encoding a polypeptide comprising (particularly consisting of) an amino acid sequence having 90% or more, particularly 95% or more, particularly 98% or more, particularly 99% or more identity to SEQ ID NO: 10 and having 3-hydroxyacyl-CoA dehydrogenase activity.
- (c10) DNA encoding a polypeptide comprising (particularly consisting of) an amino acid sequence in which 1 to 70, preferably 1 to 50, preferably 1 to 20, preferably 1 to 10, preferably 1 to 5, preferably 1 to 3, preferably 1 amino acid in the amino acid sequence of SEQ ID NO: 10 have been deleted, substituted, inserted, or added, and which has 3-hydroxyacyl-CoA dehydrogenase activity.
- SEQ ID NO: 9 is the nucleotide sequence of HPTL_0998, which is a gene of the Hydrogenophilus thermorteolus wild strain
- SEQ ID NO: 10 is the amino acid sequence of the polypeptide encoded by HPTL_0998 of the Hydrogenophilus thermorteolus wild strain.
- Examples of the above-mentioned (d) gene of a bacterium of the genus Hydrogenophilus include the following genes (d1) to (d5): (d1) DNA comprising (particularly consisting of) the base sequence of SEQ ID NO: 11 (d2) DNA containing (particularly consisting of) a nucleotide sequence having 90% or more, particularly 95% or more, particularly 98% or more, particularly 99% or more identity to the nucleotide sequence of SEQ ID NO: 11, and encoding a polypeptide having methylglutaconyl-CoA hydratase activity.
- DNA encoding a polypeptide comprising (particularly consisting of) the amino acid sequence of SEQ ID NO: 12 (d4) DNA encoding a polypeptide comprising (particularly consisting of) an amino acid sequence having 90% or more, particularly 95% or more, particularly 98% or more, particularly 99% or more identity to SEQ ID NO: 12 and having methylglutaconyl-CoA hydratase activity.
- (d5) DNA encoding a polypeptide comprising (particularly consisting of) an amino acid sequence in which 1 to 20, preferably 1 to 10, preferably 1 to 5, preferably 1 to 3, preferably 1 amino acid in the amino acid sequence of SEQ ID NO: 12 have been deleted, substituted, inserted, or added, and which has methylglutaconyl-CoA hydratase activity.
- SEQ ID NO: 11 is the nucleotide sequence of HPTL_0272, a gene of the Hydrogenophilus thermorteolus wild strain
- SEQ ID NO: 12 is the amino acid sequence of a polypeptide encoded by HPTL_0272 of the Hydrogenophilus thermorteolus wild strain.
- the identity of base sequences and amino acid sequences is a value calculated using GENETYX ver. 17 (GENETYX, manufactured by Genetyx Corporation).
- test polypeptide has 3-hydroxybutyryl-CoA dehydratase activity, enoyl-CoA hydratase activity, 3-hydroxyacyl-CoA dehydrogenase activity, or methylglutaconyl-CoA hydratase activity is confirmed by in vitro reaction of the test polypeptide with 1 mM crotonyl-CoA as a substrate at 52°C for 10 minutes, analyzing the reaction solution by high-performance liquid chromatography (HPLC), and observing the decrease in crotonyl-CoA.
- HPLC high-performance liquid chromatography
- Hydrogenophilus bacteria examples include Hydrogenophilus thermoluteolus, Hydrogenophilus halorhabdus, Hydrogenophilus denitrificans, Hydrogenophilus hirschii, Hydrogenophilus islandicus, Hydrogenophilus thiooxidans, Hydrogenophilus sp. Mar3, and Hydrogenophilus sp. Z1038.
- Hydrogenophilus thermoluteolus is preferred because it has the highest growth rate and carbon dioxide fixation ability among carbon dioxide fixation microorganisms. Hydrogenophilus bacteria can be easily isolated from all over the world.
- a preferred strain of Hydrogenophilus thermorteolus is the TH-1 (NBRC 14978) strain.
- the TH-1 (NBRC 14978) strain exhibits an extremely high growth rate (Agricultural and Biological Chemistry, 41, 685-690 (1977)) (doubling in one hour).
- the NBRC 14978 strain has been deposited internationally under the Budapest Treaty and is publicly available.
- Hydrogenophilus bacteria can be bacteria isolated from nature, or bacteria that have been genetically modified from bacteria isolated from nature. Modifications can be carried out for purposes such as enabling high expression of introduced genes. Such modifications can be carried out, for example, by disrupting genes in the genome that prevent the production of target substances, or by removing (curing) endogenous plasmids in Hydrogenophilus bacteria.
- the Hydrogenophilus bacterium mutant of the present invention can produce a substance by expressing genes inherently contained in its genome, but for the production of a target substance, metabolic enzyme genes encoding a metabolic pathway necessary for the biosynthesis of the target substance can also be introduced. That is, the mutant of the present invention can have an exogenous metabolic enzyme gene encoding a metabolic pathway necessary for the biosynthesis of the target substance.
- One or more metabolic enzyme genes can be introduced into the Hydrogenophilus bacterium mutant of the present invention, and therefore, the mutant can have one or more exogenous metabolic enzyme genes.
- the Hydrogenophilus bacterium mutant of the present invention can be used as a host for introducing an enzyme gene that catalyzes any step in the metabolic pathway that produces a target substance from crotonyl-CoA.
- Target or useful substances produced by the metabolism of crotonyl-CoA include crotyl alcohol, butadiene, butanol, etc., and one or more enzyme genes that catalyze any step in the metabolic pathway that produces these substances from crotonyl-CoA can be introduced.
- a gene introduced into a host is referred to as a "foreign gene,” whether it is an endogenous gene present in the genome of the Hydrogenophilus bacterium or a heterologous gene not present in the genome of the host Hydrogenophilus bacterium.
- the present invention provides a method for producing a target substance, comprising the step of culturing the above-described Hydrogenophilus bacterium mutant of the present invention (both the mutant and the mutant having no enzyme gene introduced therein, which catalyzes any step in the metabolic pathway for producing the target substance from crotonyl-CoA).
- This method includes the step of culturing the mutant of the present invention in an inorganic or organic medium while supplying a mixed gas containing hydrogen, oxygen, and carbon dioxide.
- the supplied gas is preferably a mixed gas consisting of hydrogen, oxygen, and carbon dioxide, but other gases may be mixed in as long as the target substance can be efficiently produced.
- Hydrogenophilus bacteria can grow using hydrogen as an energy source and carbon dioxide as the sole carbon source, and therefore can efficiently fix carbon dioxide by producing a target substance using essentially only carbon dioxide (especially using only carbon dioxide) as a carbon source. Therefore, in the method of the present invention, it is preferable to use an inorganic medium that does not contain carbon sources such as organic matter or carbonates, i.e., to culture using essentially only carbon dioxide as a carbon source (especially using carbon dioxide as the only carbon source).
- "using carbon dioxide as the sole carbon source” includes cases where unavoidable amounts of other carbon sources are mixed in.
- the pH of the medium used for the culture is preferably 6.2 to 8, more preferably 6.4 to 7.4, and even more preferably 6.6 to 7. Within this range, the growth of the bacteria and the solubility of the mixed gas in the medium are high, and the target substance can be produced with high efficiency.
- the mixed gas can be sealed in a sealed culture vessel and cultured by static culture or shaking, with shaking culture being preferred since it improves the dissolution of the mixed gas into the medium.
- the mixed gas can be continuously supplied to a sealed culture vessel while the culture is shaken, or the mutant can be cultured in a sealed culture vessel while introducing the mixed gas into the medium by bubbling.
- the volume ratio of hydrogen, oxygen, and carbon dioxide in the feed gas is preferably 1.75-7.5:1:0.25-3, more preferably 5-7.5:1:1-2, and even more preferably 6.25-7.5:1:1.5.
- the supply rate of the mixed gas or raw material gas may be 10 to 60 L/hour, preferably 10 to 40 L/hour, and more preferably 10 to 20 L/hour per L of medium.
- the culture temperature is preferably 35 to 55° C., more preferably 37 to 52° C., and even more preferably 50 to 52° C. Within this range, the mutant grows well and the target substance can be produced efficiently.
- the target substance is produced in the culture medium.
- the target substance can be recovered by collecting the culture medium, but it can also be separated from the reaction solution using known methods. Such known methods include membrane separation and distillation.
- Example 1 Functional verification of candidate side reaction enzymes expressed in E. coli
- genes for 14 enzymes SEQ ID NOs: 3, 5, 7, 9, 11, 12, 13-20
- the gene sequences cloned into each plasmid were confirmed to be correct by DNA sequencing.
- the genes for 14 enzymes that are thought to be potential side effects are listed below.
- HPTL_1099 (SEQ ID NO: 3) HPTL_0565 (SEQ ID NO: 1) HPTL_0624 (SEQ ID NO: 7) HPTL_0998 (SEQ ID NO: 9) HPTL_1333 (SEQ ID NO: 5) HPTL_0272 (SEQ ID NO: 11) HPTL_1429 (SEQ ID NO: 13) HPTL_1650 (SEQ ID NO: 14) HPTL_1427 (SEQ ID NO: 15) HPTL_0993 (SEQ ID NO: 16) HPTL_0471 (SEQ ID NO: 17) HPTL_0239 (SEQ ID NO: 18) HPTL_0472 (SEQ ID NO: 19) HPTL_1001 (SEQ ID NO: 20)
- E. coli JM109 strain was transformed with each of the plasmids containing the 14 enzyme genes listed above.
- Each transformant colony grown on LB agar medium containing 50 ⁇ g/mL kanamycin was cultured overnight at 37°C with shaking in a test tube containing 5 mL of LB liquid medium containing 50 ⁇ g/mL kanamycin.
- each target enzyme is expressed without the addition of an inducer by the tac promoter contained in pCAMO-6.
- 2 mL of the overnight culture was centrifuged (4°C, 5,000 g, 10 minutes) to recover the bacterial cells.
- the recovered bacterial cells were suspended in 300 ⁇ L of 100 mM Tris-HCl (pH 7.5) buffer and disrupted by ultrasound.
- Crotonyl-CoA was added to each bacterial cell lysate to a final concentration of 1 mM, mixed, and incubated at 52°C for 10 minutes. Reaction samples collected 5 and 10 minutes after the start of the reaction were analyzed by HPLC to detect crotonyl-CoA and 3-hydroxybutyryl-CoA. Crotonyl-CoA and 3-hydroxybutyryl-CoA were also detected in the E. coli JM109 strain containing the empty vector pCAMO-6.
- FIGS 3A and 3B The HPLC chromatograms are shown in Figures 3A and 3B.
- Figures 3A and 3B include chromatograms taken after 5 and 10 minutes.
- the results showed that the bacterial cell lysates expressing HPTL_1099, HPTL_0565, HPTL_0624, HPTL_0998, HPTL_1333, and HPTL_0272 either produced less crotonyl-CoA than the empty vector, or the amount of crotonyl-CoA was lower after 10 minutes than after 5 minutes.
- HPTL_0565, HPTL_0998, HPTL_1333, and HPTL_0272 produced more 3-hydroxybutyryl-CoA than the empty vector.
- HPTL_1099, HPTL_0565, HPTL_0624, HPTL_0998, HPTL_1333, and HPTL_0272 were thought to be enzyme genes that catalyze side reactions that interfere with the reaction that produces useful substances from crotonyl-CoA.
- the strain expressing the HPTL_0565 gene had the greatest reduction in crotonyl-CoA and possessed the strongest side reaction activity.
- Example 2 Preparation of a gene-disrupted strain of HPTL_0565 A gene-disrupted strain of HPTL_0565, which had the highest side reaction activity in Example 1, was obtained by homologous recombination using a wild-type strain of Hydrogenophilus thermorteolus TH-1 (NBRC 14978).
- TH-1 strain Hydrogenophilus thermorteolus TH-1 strain (NBRC 14978) (hereinafter referred to as "TH-1 strain") was cultured in liquid medium A [( NH4 ) 2SO4 3.0 g, KH2PO4 1.0 g, K2HPO4 2.0 g, NaCl 0.25 g, FeSO4 ⁇ 7H2O 0.014 g, MgSO4 ⁇ 7H2O 0.5 g , CaCl2 0.03 g, MoO3 4.0 mg, ZnSO4 ⁇ 7H2O 28 mg, CuSO4 ⁇ 5H2O 2.0 mg, H3BO3 4.0 mg, MnSO4 ⁇ 5H2O 4.0 mg, CoCl2 ⁇ 6H2O 4.0 mg ] .
- Genomic DNA was extracted from a wild-type TH-1 strain (a streptomycin-sensitive strain) according to standard methods. Using the extracted genomic DNA as a template, a DNA fragment containing the rpsL gene, which encodes the S12 ribosomal protein and is responsible for streptomycin sensitivity, was amplified by PCR.
- primers for amplifying the wild-type rpsL gene of the TH-1 strain (a-2) 5'-CTGGAGGAGAAACGCATATGCCAACCATCAACCAGTTGGTG-3' (SEQ ID NO: 24) (b-2) 5'-CGACGGAGCTCGAATTCTTATTTCTTGCCCGCAGCGGC-3' (SEQ ID NO: 25)
- Primer (a-2) and primer (b-2) contain sequences homologous to the vector pCAMO-6.
- a DNA fragment of approximately 0.4 kbp corresponding to the rpsL gene of the wild-type TH-1 strain was detected, and the DNA fragment was recovered from the gel.
- the DNA fragment of vector pCAMO-6 and the DNA fragment of rpsL were ligated together and used to transform Escherichia coli strain JM109. Plasmid was then extracted and the sequence of the rpsL gene was confirmed.
- the rpsL gene containing the tac promoter region was amplified using pCAMO-6, into which the rpsL gene had been introduced, as a template.
- Primer (a-3) for amplifying the rpsL gene containing the tac promoter region 5'-CATAACGGTTCTGGCAAATATTC-3' (SEQ ID NO: 26)
- b-3) 5'-GCCATATGCGATACTCCTCCTCATTTCTTGCCCGCAGCGGCGCC-3' SEQ ID NO: 27
- the primer (b-3) contains a sequence required for binding to the bleomycin resistance gene.
- a DNA fragment of about 0.4 kbp corresponding to the rpsL gene containing the tac promoter region was detected, and the DNA fragment was recovered from the gel.
- (3-2) Preparation of a positive selection marker Using artificially synthesized (partially codon-substituted) DNA from Streptoalloteichus hindustanus as a template, a DNA fragment of the bleomycin resistance gene sequence was amplified by PCR using the following primers: (a-4) 5'-GAAATGAGGAGGAGTATCGCATATGGCTAAACTTACTTCTGCTG-3' (SEQ ID NO: 28) (b-4) 5'-TCAATCTTGTTCCTCTGCAACAAAATG-3' (SEQ ID NO: 29)
- the primer (a-4) contains a sequence necessary for binding to the rpsL gene. As a result of electrophoresis, a DNA fragment of approximately 0.4 kbp corresponding to the bleomycin resistance gene was detected, and the DNA fragment was recovered from the gel.
- Primer (a-6) for amplifying the 5' region of the HPTL_0565 gene 5'-CTTCTCCCGAGCCCAATCGCGGG-3' (SEQ ID NO: 32)
- b-6) 5'-CAGAATATTTGCCAGAACCGTTATGTTAAGCCAAGATATCGGCTTCCGAAACGG-3' (SEQ ID NO: 33)
- the primer (b-6) contains a sequence required for binding to the marker cassette.
- Primer (a-7) for amplifying the 3' region of the HPTL_0565 gene 5'-CATTTTGTTGCAGAGGAACAAGATTGAATCTCGACGCGGAGTTCGCG-3' (SEQ ID NO: 34)
- b-7) 5'-GTGGTTGCTCTGCTTGCGCC-3' (SEQ ID NO: 35)
- the primer (a-7) contains a sequence required for binding to the marker cassette.
- DNA fragments of approximately 1.7 kbp and approximately 1.3 kbp corresponding to the 5' and 3' regions of the HPTL_0565 gene were detected, respectively, and the DNA fragments were recovered from the gel.
- the DNA region containing the HPTL_0565 gene was amplified by PCR.
- the following primers were used for PCR.
- PCR was performed using a combination of primers (a-6) and (b-7), a DNA region of approximately 4.2 kbp was amplified if the HPTL_0565 gene was replaced with the marker cassette.
- Example 3 Confirmation of the reduction in by-product reaction ability of the HPTL_0565 gene-disrupted strain No. 1
- the wild-type strain and the HPTL_0565 gene disruptant were inoculated into 5 mL of liquid medium A in a test tube using a platinum loop.
- Bacterial cells were harvested from 2 mL of the culture by centrifugation (4°C, 5,000 g, 10 minutes). Each cell was suspended in 300 ⁇ L of 100 mM Tris-HCl (pH 7.5) and disrupted by sonication.
- Crotonyl-CoA was added as a reaction substrate to each bacterial cell lysate to a final concentration of 1 mM (the initial concentration in the reaction solution), and the reaction was initiated at 52°C. 50 ⁇ L of the reaction solution was sampled at 1, 2, 3, 5, 10, 15, and 30 minutes after the start of the reaction. The samples taken at each time point were analyzed by HPLC to detect crotonyl-CoA. 3-Hydroxybutyryl-CoA was also detected. As a result, in the wild-type strain sample, 1 mM crotonyl-CoA used in the reaction was rapidly consumed, and the detected crotonyl-CoA decreased to less than 0.1 mM after 1 minute of reaction.
- Example 4 Confirmation of the reduction in by-product reaction ability of the HPTL_0565 gene-disrupted strain No. 2 Using the same sample as in Example 3, crotonyl-CoA and 3-hydroxybutyryl-CoA were detected over time by HPLC in the same manner as in Example 3, except that the reaction substrate was changed to 3-hydroxybutyryl-CoA.
- the purpose of this example was to produce hydroxybutyryl-CoA and crotonyl-CoA from 1 mM 3-hydroxybutyryl-CoA added to the reaction system using endogenous enzymes present in the cell lysate of Hydrogenophilus thermorteolus, and to compare the detected amounts between the wild-type strain and the HPTL_0565 gene-disrupted strain to verify the effect of HPTL_0565 gene disruption on improving the production (supply) of crotonyl-CoA. Because the substrate was 3-hydroxybutyryl-CoA, this example was evaluated under conditions closer to the natural state than in Example 3.
- the amount of crotonyl-CoA detected in the HPTL_0565-disrupted strain was approximately four times higher than that in the wild-type strain, confirming that HPTL_0565 gene disruption can increase the amount of crotonyl-CoA produced (Figure 5).
- SEQ ID Nos: 1 to 21 are shown below.
- the Hydrogenophilus bacterial mutant of the present invention can be used to efficiently produce useful substances such as crotyl alcohol, butadiene, and butanol, which are produced via crotonyl-CoA, while also solving the problem of global warming caused by increased carbon dioxide, thereby meeting demand for the production of chemical products such as plastics, rubber, fibers, polymers, and biofuels.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
本発明は、クロトニルCoAの生成能が向上していることにより、その代謝により生成する様々な有用物質の生産能を向上させることができるヒドロゲノフィラス属細菌変異体に関する。 The present invention relates to a mutant Hydrogenophilus bacterium that has improved crotonyl-CoA production ability, thereby improving its ability to produce various useful substances produced by its metabolism.
2015年採択のパリ協定は、世界全体の温室効果ガスの排出量を迅速に削減することを定めている。これに従い、日本は2030年までに、二酸化炭素やメタンなどの温室効果ガス排出量を2013年に比べて46%削減することを目標としている。 The Paris Agreement, adopted in 2015, calls for rapid reductions in global greenhouse gas emissions. In accordance with this agreement, Japan aims to reduce its greenhouse gas emissions, including carbon dioxide and methane, by 46% by 2030 compared to 2013 levels.
世界的に化学品製造の大半は石油原料に依存しており、温室効果ガスの排出量増大といった問題がある。従って、化学品製造の脱石油化が求められており、バイオマスからグリーン化学品を製造するバイオリファイナリーの研究開発が各国で精力的に行われている。しかし、微生物発酵の原料とするためのバイオマスの糖類への変換には複雑な工程が必要であり、高コストとなる課題がある。また、食料や飼料となり得るバイオマスを化学品製造に利用することは食料や飼料の安定供給を妨げる。さらに、バイオマスを化学品製造に大量に消費することが、却って環境破壊をもたらすという問題もある。 Globally, the majority of chemical production relies on petroleum as raw materials, resulting in problems such as rising greenhouse gas emissions. Therefore, there is a need to move away from petroleum-based chemical production, and research and development into biorefineries that produce green chemicals from biomass is being actively carried out in various countries. However, converting biomass into sugars to use as a feedstock for microbial fermentation requires complex processes, posing a high cost issue. Furthermore, using biomass that can be used as food or feed in chemical production hinders the stable supply of food and feed. Furthermore, there is also the problem that consuming large amounts of biomass in chemical production actually leads to environmental destruction.
脱石油化の研究の一環として、より高度のサステナビリティを有する炭素原料として二酸化炭素、メタン、一酸化炭素などのガスが注目されており、これらのガスを利用する微生物を用いて有価化学品やバイオ燃料を製造する技術に関心が寄せられている。中でも、温暖化への寄与率が高い二酸化炭素を固定して有効利用することへの期待が高い。 As part of research into moving away from petroleum, gases such as carbon dioxide, methane, and carbon monoxide are attracting attention as more sustainable carbon feedstocks, and there is growing interest in technologies that use microorganisms to utilize these gases to produce valuable chemicals and biofuels. In particular, there are high hopes for fixing and effectively utilizing carbon dioxide, which contributes significantly to global warming.
ここで、クロトニルCoAを経由して生成する有用化学物質の例として、クロチルアルコール、ブタジエン、ブタノールが挙げられる。 Examples of useful chemicals produced via crotonyl CoA include crotyl alcohol, butadiene, and butanol.
ブタジエンは、ブタジエンゴム、スチレンブタジエンゴム、アクリロニトリル・ブタジエンゴム、クロロプレンゴムのような合成ゴムや、スチレンブタジエンアクリロニトリル(ABS)樹脂、スチレンブタジエンメタクリレート(MBS)樹脂のような合成樹脂の原料として利用されている。また、アジポニトリル、1,4-ブタンジオール、シクロドデカトリエン、クロロプレン、スルホランのようなその他の化成品の原料としても利用されている。 Butadiene is used as a raw material for synthetic rubbers such as butadiene rubber, styrene-butadiene rubber, acrylonitrile-butadiene rubber, and chloroprene rubber, and synthetic resins such as styrene-butadiene-acrylonitrile (ABS) resin and styrene-butadiene methacrylate (MBS) resin. It is also used as a raw material for other chemical products such as adiponitrile, 1,4-butanediol, cyclododecatriene, chloroprene, and sulfolane.
現在製造されているブタジエンのほとんどは、石油化学の技術を用いて生産されているため、脱石油化やサステナブル化を目指して、微生物を用いてブタジエンを製造する技術が試みられている。図1に示すように、多くの微生物は、ピルビン酸からクロトニルCoAとクロチルアルコール(クロトニルアルコール)を経てブタジエンを生成する代謝経路を有するが、通常は工業レベルでブタジエンを製造させることはできない。このため、この代謝経路を構成する酵素をコードする外来遺伝子の1以上を宿主に導入した形質転換体を培養することによりブタジエンを製造する方法が種々提案されている。 As most butadiene currently produced is produced using petrochemical technology, attempts are being made to develop technologies to produce butadiene using microorganisms in an effort to move away from petroleum dependence and achieve sustainability. As shown in Figure 1, many microorganisms have a metabolic pathway that produces butadiene from pyruvate via crotonyl CoA and crotyl alcohol (crotonyl alcohol), but it is not usually possible to produce butadiene on an industrial scale. For this reason, various methods have been proposed for producing butadiene by culturing a transformant in which one or more foreign genes encoding the enzymes that make up this metabolic pathway have been introduced into the host.
ブタノールは、化学産業、製薬、及び石油産業などの工業部門において幅広い用途を有する有機化学原料である。被覆材、プラスチック、織物、接着剤などの製造に使用されるアクリル酸及びメタクリル酸エステル;被覆材、電子工学製品の製造に使用されるグリコールエーテル;ペンキ、インク、被覆材、合成果実様芳香剤の製造に使用される酢酸ブチル;殺虫剤、医薬品の製造に使用されるブチルアミン;及びアミン樹脂などの製造に使用される。また、ブタノール自体、インク、染料などに含まれる溶媒、抽出溶媒、凍結防止流体、化粧品成分、及びクロマトグラフィーの溶離液成分といった直接的用途を有する。
特に、炭素数4のブタノールは、炭素数2のエタノールより燃料効率が高く、ガソリンやディーゼル油への混合が容易であり、低腐食性、低含水性であるなどの多くの利点を有しているため、バイオエタノールに続く次世代バイオ燃料としても注目されている。
Butanol is an organic chemical raw material with a wide range of applications in industrial sectors such as the chemical, pharmaceutical, and petroleum industries. It is used to manufacture acrylic and methacrylic acid esters, which are used in the production of coatings, plastics, textiles, and adhesives; glycol ethers, which are used in the production of coatings and electronic products; butyl acetate, which is used in the production of paints, inks, coatings, and synthetic fruit fragrances; butylamine, which is used in the production of pesticides and pharmaceuticals; and amine resins. Butanol also has direct uses as a solvent in inks and dyes, extraction solvent, antifreeze fluid, cosmetic ingredient, and chromatography eluent component.
In particular, butanol, which has four carbon atoms, has many advantages over ethanol, which has two carbon atoms: it is more fuel efficient, it can be easily mixed with gasoline or diesel oil, and it has low corrosiveness and low water content. Therefore, it is attracting attention as a next-generation biofuel to follow bioethanol.
微生物によるブタノール生成方法として、増殖が比較的速い好気性細菌又は通性嫌気性細菌を用いてブタノールを製造する技術が試みられている。
絶対嫌気性菌のクロストリジウム属細菌は、図2に示す、グルコースからピルビン酸、アセチルCoA、クロトニルCoA、ブチリルCoAを介してブタノールを生成する代謝経路を有することから、この代謝経路を参照して、本来ブタノールを生成しない細菌に、ピルビン酸からブチリルCoAを介したブタノールまでの代謝経路を構築することが可能である。
非特許文献1によれば、好気性細菌及び通性嫌気性細菌では、クロトニルCoAからブチリルCoAの反応において、脂肪酸合成や脂肪酸のベータ酸化経路などによるエノイルCoAの還元反応が遍在していることから、グルコースからブチリルCoAを生成することは理論的には可能である。しかし、好気性細菌及び通性嫌気性細菌は、実際には、ブチリルCoAからブタノールを生成することができない。このため、ブチリルCoAからブタノールを生成する代謝経路を触媒する酵素をコードする外来遺伝子の1以上を好気性細菌や通性嫌気性細菌の宿主に導入した形質転換体を培養することによりブタノールを製造する方法が種々提案されている。
As a method for producing butanol using microorganisms, techniques have been attempted in which butanol is produced using aerobic bacteria or facultative anaerobic bacteria, which grow relatively quickly.
Clostridium bacteria, which are obligate anaerobes, have a metabolic pathway shown in Figure 2 that produces butanol from glucose via pyruvate, acetyl-CoA, crotonyl-CoA, and butyryl-CoA. By referring to this metabolic pathway, it is possible to construct a metabolic pathway from pyruvate to butyryl-CoA and then to butanol in bacteria that do not naturally produce butanol.
According to Non-Patent Document 1, in aerobic bacteria and facultative anaerobic bacteria, the reduction reaction of enoyl-CoA via fatty acid synthesis, fatty acid beta-oxidation pathways, etc., is ubiquitous in the reaction of crotonyl-CoA to butyryl-CoA, and therefore it is theoretically possible to produce butyryl-CoA from glucose. However, aerobic bacteria and facultative anaerobic bacteria cannot actually produce butyryl-CoA from butyryl-CoA. For this reason, various methods for producing butanol have been proposed, in which a transformant is cultured in which one or more foreign genes encoding enzymes that catalyze the metabolic pathway for producing butyryl-CoA from butyryl-CoA are introduced into an aerobic or facultative anaerobic host.
水素と酸素の反応によって生じる化学エネルギーを利用し、二酸化炭素を唯一の炭素源として生育できる水素細菌は、酸素、水素、及び二酸化炭素の混合ガスを原料として化学品を製造できるため、二酸化炭素を効率よく有機化することができ、また、糖などの有機物を含まない単純な培地で培養することができる。
一般的に水素細菌の生育は遅いが、水素細菌の中でヒドロゲノフィラス属細菌は増殖速度が格段に速い。「三菱総合研究所報 No.34 1999」ではヒドロゲノフィラス属細菌を、『この増殖能力は植物の持つ炭酸固定能力とは比較出来ない程の高い効率であり、微生物の炭酸固定能力の高さを如実に物語っている』と評価している。このため、二酸化炭素を資源として有価物を得るためにヒドロゲノフィラス属細菌を使用したいという要求がある。
Hydrogen bacteria can grow using carbon dioxide as the sole carbon source, utilizing the chemical energy generated by the reaction of hydrogen and oxygen. This allows them to produce chemical products using a mixture of oxygen, hydrogen, and carbon dioxide as raw materials, enabling them to efficiently organicize carbon dioxide. They can also be cultured in simple media that do not contain organic substances such as sugars.
Generally, hydrogen bacteria grow slowly, but among hydrogen bacteria, the Hydrogenophilus bacteria grow at an exceptionally fast rate. The Mitsubishi Research Institute Report No. 34, 1999, praised the Hydrogenophilus bacteria, saying, "Their growth rate is so high that it cannot be compared to the carbon dioxide fixation ability of plants, and it clearly demonstrates the high carbon dioxide fixation ability of microorganisms." For this reason, there is a demand to use Hydrogenophilus bacteria to obtain valuable products from carbon dioxide as a resource.
本発明は、クロトニルCoAの生成能が向上していることにより、クロトニルCoAを経由して生成する有用な物質の効率的な生産に使用できるヒドロゲノフィラス(Hydrogenophilus)属細菌変異体を提供することを主な課題とする。 The primary objective of the present invention is to provide a mutant Hydrogenophilus bacterium that has improved crotonyl-CoA production ability and can therefore be used for the efficient production of useful substances produced via crotonyl-CoA.
本発明者は、上記課題を解決するために研究を重ね、以下の知見を得た。
(1) ヒドロゲノフィラス属細菌は、図1に示すピルビン酸からクロトニルCoAを生成する代謝経路を有している。ところが、ヒドロゲノフィラス属細菌は、クロトニルCoAを3-ヒドロキシブチリル-CoAに変換する代謝経路も有しており、この代謝経路が働くと、クロトニルCoAからクロチルアルコールを経てブタジエンを製造する場合や、クロトニルCoAからブチリルCoAを経てブタノールを製造する場合に、目的生産物の生産量が少なくなる。
The present inventors have conducted extensive research to solve the above problems and have obtained the following findings.
(1) Hydrogenophilus bacteria possess a metabolic pathway for producing crotonyl-CoA from pyruvate, as shown in Figure 1. However, Hydrogenophilus bacteria also possess a metabolic pathway for converting crotonyl-CoA to 3-hydroxybutyryl-CoA. When this metabolic pathway is active, the production of the target product decreases when butadiene is produced from crotonyl-CoA via crotyl alcohol, or when butanol is produced from crotonyl-CoA via butyryl-CoA.
(2) 本発明者は、ヒドロゲノフィラス属細菌の14種類の酵素が、このような目的生産物の生成を減少させる副反応を触媒する可能性があると予測し、ヒドロゲノフィラス サーモルテオラス(Hydrogenophilus thermolluteolus)のこれら14種の酵素の遺伝子を大腸菌で発現させて、副反応活性を評価した。その結果、HPTL_0565(配列番号1)、HPTL_1099(配列番号3)、HPTL_1333(配列番号5)、HPTL_0624(配列番号7)、HPTL_0998(配列番号9)、及びHPTL_0272(配列番号11)の遺伝子がそれぞれコードする酵素が、クロトニルCoAを基質として3-ヒドロキシブチリル-CoAを生成する活性を有していることを見出した。HPTL_0565(配列番号3)がコードする酵素は最も強い活性を示した(図3A、図3B)。これら6種の酵素は副反応を触媒することが分かった (2) The inventors predicted that 14 enzymes from Hydrogenophilus bacteria may catalyze side reactions that reduce the production of the target product. They expressed the genes for these 14 enzymes from Hydrogenophilus thermolluteolus in Escherichia coli and evaluated their side reaction activity. They found that the enzymes encoded by the genes HPTL_0565 (SEQ ID NO: 1), HPTL_1099 (SEQ ID NO: 3), HPTL_1333 (SEQ ID NO: 5), HPTL_0624 (SEQ ID NO: 7), HPTL_0998 (SEQ ID NO: 9), and HPTL_0272 (SEQ ID NO: 11) each possess the activity to produce 3-hydroxybutyryl-CoA from crotonyl-CoA as a substrate. The enzyme encoded by HPTL_0565 (SEQ ID NO: 3) exhibited the strongest activity (Figures 3A and 3B). These six enzymes were found to catalyze side reactions.
(3) さらに、本発明者は、ヒドロゲノフィラス サーモルテオラスのゲノム上のHPTL_0565(配列番号1)を破壊した株と、破壊前の野生株について、菌体破砕液のクロトニルCoAを基質とした酵素活性を評価した。その結果、野生株では、酵素反応開始1分後にはクロトニルCoAがほぼ消失したのに対して、HPTL_0565を破壊した株では、酵素反応開始30分後にもクロトニルCoAが残存していた(図4)。
また、本発明者は、ヒドロゲノフィラス サーモルテオラスのゲノム上のHPTL_0565(配列番号1)を破壊した株と、破壊前の野生株について、菌体破砕液の3-ヒドロキシブチリル-CoAを基質とした酵素活性を評価した。その結果、HPTL_0565を破壊した株では、野生株に比べて、クロトニルCoAの量が多かった(図5)。
これらの結果から、ヒドロゲノフィラス サーモルテオラスのゲノム上のHPTL_0565、HPTL_1099、HPTL_1333、HPTL_0624、HPTL_0998、及びHPTL_0272の1以上を破壊した株ではクロトニルCoA量が増えているため、クロトニルCoAを経て生成されるクロチルアルコール、ブタジエン、ブタノールといった有用物質の製造効率が高くなることが分かった。他のヒドロゲノフィラス属細菌でも対応する遺伝子を破壊することで同様の効果が得られる。
(3) Furthermore, the present inventors evaluated the enzyme activity of a strain in which HPTL_0565 (SEQ ID NO: 1) on the genome of Hydrogenophilus thermorteolus was disrupted and a wild-type strain before disruption, using crotonyl-CoA as a substrate in the cell lysate. As a result, in the wild-type strain, crotonyl-CoA had almost completely disappeared 1 minute after the start of the enzymatic reaction, whereas in the HPTL_0565-disrupted strain, crotonyl-CoA remained even 30 minutes after the start of the enzymatic reaction (Figure 4).
The present inventors also evaluated the enzyme activity of a strain in which HPTL_0565 (SEQ ID NO: 1) on the genome of Hydrogenophilus thermorteolus was disrupted and a wild-type strain before disruption, using 3-hydroxybutyryl-CoA from the cell lysate as a substrate. As a result, the strain in which HPTL_0565 was disrupted produced a higher amount of crotonyl-CoA than the wild-type strain (Figure 5).
These results indicate that strains in which one or more of HPTL_0565, HPTL_1099, HPTL_1333, HPTL_0624, HPTL_0998, and HPTL_0272 on the Hydrogenophilus thermorteolus genome have been disrupted have increased amounts of crotonyl-CoA, which increases the efficiency of production of useful substances such as crotyl alcohol, butadiene, and butanol, which are produced via crotonyl-CoA. Similar effects can be obtained in other Hydrogenophilus bacteria by disrupting the corresponding genes.
本発明は、上記知見に基づき完成されたものであり、下記の〔1〕~〔4〕を提供する。
〔1〕 下記(a)~(d)の、ヒドロゲノフィラス属細菌の染色体上に存在する、クロトニルCoAから3-ヒドロキシブチリル-CoAを生成する経路の何れかの反応を触媒する酵素遺伝子の1つ以上(少なくとも1つ)が破壊されたヒドロゲノフィラス属細菌変異体。
(a) 3-ヒドロキシブチリル-CoAデヒドラターゼ活性を有するポリペプチドをコードする遺伝子
(b) エノイルCoAヒドラターゼ活性を有するポリペプチドをコードする遺伝子
(c) 3-ヒドロキシアシル-CoAデヒドロゲナーゼ活性を有するポリペプチドをコードする遺伝子
(d) メチルグルタコニル-CoAヒドラターゼ活性を有するポリペプチドをコードする遺伝子
〔2〕 上記(a)~(d)の1つ以上の遺伝子において、全領域又は一部領域が欠失しているか、ヌクレオチドが挿入又は付加されているか、全領域又は一部領域が他のヌクレオチドに置換されていることによりその遺伝子が破壊されている、〔1〕の変異体。
〔3〕 目的物質生産のための外来遺伝子を有する、〔1〕又は〔2〕の変異体。
〔4〕 〔3〕の変異体を培養する工程を含む目的物質の製造方法。
The present invention was completed based on the above findings and provides the following [1] to [4].
[1] A Hydrogenophilus bacterium mutant in which one or more (at least one) of the enzyme genes present on the chromosome of the Hydrogenophilus bacterium, which catalyze any reaction in the pathway that produces 3-hydroxybutyryl-CoA from crotonyl-CoA, are disrupted:
(a) A gene encoding a polypeptide having 3-hydroxybutyryl-CoA dehydratase activity
(b) a gene encoding a polypeptide having enoyl-CoA hydratase activity
(c) a gene encoding a polypeptide having 3-hydroxyacyl-CoA dehydrogenase activity
(d) A gene encoding a polypeptide having methylglutaconyl-CoA hydratase activity [2] A mutant of [1] in which one or more of the genes (a) to (d) above have been disrupted by deletion of the entire region or a portion thereof, insertion or addition of nucleotides, or substitution of the entire region or a portion thereof with other nucleotides.
[3] A mutant of [1] or [2] having an exogenous gene for producing a target substance.
[4] A method for producing a target substance, comprising the step of culturing the mutant of [3].
二酸化炭素の増加を抑制する対策として、二酸化炭素の排出量の低減と排出された二酸化炭素の固定がある。二酸化炭素の排出量を低減するために、化石エネルギーに代えて太陽、風力、地熱などのエネルギーの利用が行われている。しかし、現実には、このようなエネルギーの利用によっても二酸化炭素の増加を十分に抑制できていない。そこで、排出された二酸化炭素の固定又は資源化を進める必要がある。
二酸化炭素は、物理的又は化学的に固定することもできるが、生物を利用して二酸化炭素を固定すれば、それにより食料、飼料、燃料などとして利用できる有機物や、化成品原料を生産することができる。即ち、二酸化炭素そのものを資源として直接的に有価物に変換することができる。これにより、二酸化炭素の増加による地球温暖化と、食料、飼料、燃料、化成品原料の確保困難という2つの問題を共に解決できる。
Measures to curb the increase in carbon dioxide include reducing carbon dioxide emissions and fixing emitted carbon dioxide. To reduce carbon dioxide emissions, energy sources such as solar, wind, and geothermal energy are being used in place of fossil fuels. However, in reality, the use of these types of energy sources has not been enough to sufficiently curb the increase in carbon dioxide. Therefore, it is necessary to promote the fixation or resource recovery of emitted carbon dioxide.
Carbon dioxide can be fixed physically or chemically, but if it is fixed using living organisms, it can be used to produce organic matter that can be used as food, feed, fuel, etc., or as raw materials for chemical products. In other words, carbon dioxide itself can be directly converted into a valuable resource. This can solve two problems: global warming caused by increased carbon dioxide, and the difficulty in securing food, feed, fuel, and raw materials for chemical products.
本発明の変異体は、増殖速度が非常に速いことにより物質生産能力が極めて高いヒドロゲノフィラス属細菌において、ゲノム上の、クロトニルCoAから有用物質を生成する経路の副反応経路を触媒する酵素の遺伝子が破壊されているため、クロトニルCoAを経て生成するクロチルアルコール、ブタジエン、及びブタノールといった有用物質の製造に用いれば、その製造効率を向上させることができる。ヒドロゲノフィラス属細菌は、クロトニルCoAからクロチルアルコール、ブタジエン、又はブタノールを生成する反応を触媒する酵素遺伝子を有さないため、本発明の変異体にこれらの酵素遺伝子を導入すれば、得られる形質転換体は、極めて効率よくこれらの有用物質を生産するようになる。
従って、本発明のヒドロゲノフィラス属細菌変異体は、二酸化炭素の増加による地球温暖化問題を解決しながら、プラスチック、ゴム、繊維、ポリマー、バイオ燃料などの化成品製造の需要に応えることができる。
The mutant of the present invention is a Hydrogenophilus bacterium with an extremely high growth rate and therefore extremely high substance-producing capacity, in which the gene encoding an enzyme that catalyzes a side reaction pathway in the pathway for producing useful substances from crotonyl-CoA has been disrupted in its genome, and therefore, when used to produce useful substances such as crotyl alcohol, butadiene, and butanol, which are produced via crotonyl-CoA, the production efficiency can be improved. Because Hydrogenophilus bacteria do not have the enzyme genes that catalyze the reactions that produce crotyl alcohol, butadiene, or butanol from crotonyl-CoA, by introducing these enzyme genes into the mutant of the present invention, the resulting transformant will produce these useful substances extremely efficiently.
Therefore, the mutant Hydrogenophilus bacterium of the present invention can solve the problem of global warming caused by increased carbon dioxide, while meeting the demand for the production of chemical products such as plastics, rubber, fibers, polymers, and biofuels.
以下、本発明を詳細に説明する。
(1)ヒドロゲノフィラス属細菌変異体
本発明のヒドロゲノフィラス属細菌変異体は、ヒドロゲノフィラス属細菌の染色体上に存在する、下記(a)~(d)の1つ以上の遺伝子が破壊された変異体である。下記(a)~(d)の遺伝子がコードする酵素は、それ単独で又は他の酵素と共にクロトニルCoAから3-ヒドロキシブチリル-CoAを生成する。
(a)~(d)の各遺伝子としては、構造が異なる2種以上の遺伝子が存在し得る。従って、「(a)~(d)の1つ以上の遺伝子が破壊された」は、例えば(a)の遺伝子と(b)の遺伝子が破壊されている場合や、(b)の遺伝子に該当する複数種の遺伝子が破壊されている場合を含む。
(a) 3-ヒドロキシブチリル-CoAデヒドラターゼ(3-hydroxybutyryl-CoA dehydratase)活性を有するポリペプチドをコードする遺伝子
ヒドロゲノフィラス サーモルテオラスでは、(a)の遺伝子としてHPTL_0565が挙げられる。
(b) エノイルCoAヒドラターゼ(enoyl-CoA hydratase)活性を有するポリペプチドをコードする遺伝子
ヒドロゲノフィラス サーモルテオラスでは、(b)の遺伝子としてHPTL_1099及びHPTL_1333が挙げられる。
(c) 3-ヒドロキシアシル-CoAデヒドロゲナーゼ(3-hydroxyacyl-CoA dehydrogenase)活性を有するポリペプチドをコードする遺伝子
ヒドロゲノフィラス サーモルテオラスでは、(c)の遺伝子としてHPTL_0624及びHPTL_0998が挙げられる。
(d) メチルグルタコニル-CoAヒドラターゼ(methylglutaconyl-CoA hydratase)活性を有するポリペプチドをコードする遺伝子
ヒドロゲノフィラス サーモルテオラスでは、(d)の遺伝子としてHPTL_0272が挙げられる。
The present invention will be described in detail below.
(1) Hydrogenophilus bacterium mutant The Hydrogenophilus bacterium mutant of the present invention is a mutant in which one or more of the following genes (a) to (d) present on the chromosome of a Hydrogenophilus bacterium have been disrupted: The enzymes encoded by the following genes (a) to (d) produce 3-hydroxybutyryl-CoA from crotonyl-CoA, either alone or in combination with other enzymes:
For each of genes (a) to (d), two or more genes with different structures may exist. Therefore, "one or more genes (a) to (d) are disrupted" includes, for example, cases where gene (a) and gene (b) are disrupted, and cases where multiple genes corresponding to gene (b) are disrupted.
(a) A gene encoding a polypeptide having 3-hydroxybutyryl-CoA dehydratase activity. In Hydrogenophilus thermorteolus, an example of the gene (a) is HPTL_0565.
(b) A gene encoding a polypeptide having enoyl-CoA hydratase activity. In Hydrogenophilus thermorteolus, examples of the genes of (b) include HPTL_1099 and HPTL_1333.
(c) A gene encoding a polypeptide having 3-hydroxyacyl-CoA dehydrogenase activity. In Hydrogenophilus thermorteolus, examples of the genes in (c) include HPTL_0624 and HPTL_0998.
(d) A gene encoding a polypeptide having methylglutaconyl-CoA hydratase activity. In Hydrogenophilus thermorteolus, an example of the gene (d) is HPTL_0272.
遺伝子の破壊
本発明において、「遺伝子の破壊」は、各遺伝子の産物の活性が、破壊させる前の親株の50%以下になることをいう。好ましくは、10%以下、特に1%以下になることである。これにより、クロトニルCoAから3-ヒドロキシブチリル-CoAの生成が親株より少なくなる。遺伝子産物の活性はその触媒する酵素活性の測定により評価する。
遺伝子の発現量が低下すると遺伝子産物の活性が低下する。遺伝子の発現量は、定量PCR法(qPCR)や次世代シークエンシング法(NGS)により測定することができる。また、遺伝子のコード領域や発現調節領域の一部が変異しても遺伝子は正常に発現する場合があるが、その場合でも遺伝子産物の活性が親株の50%以下になっていれば、「遺伝子の破壊」に該当する。
遺伝子の破壊は、ヒドロゲノフィラス属細菌の染色体上にある当該遺伝子のコード領域やプロモーター領域のような遺伝子発現調節領域を変異(塩基の欠損、置換、挿入、付加、及びこれらの組み合わせ)させることにより行える。遺伝子の破壊方法は良く知られており、例えば、相同組換えを用いた遺伝子ノックアウト法、突然変異原を用いたランダムな遺伝子突然変異の導入と表現型に基づくスクリーニング法などが挙げられる。
Gene Disruption In the present invention, "gene disruption" refers to reducing the activity of the product of each gene to 50% or less of that of the parent strain before disruption. Preferably, it is 10% or less, and particularly 1% or less. This results in less production of 3-hydroxybutyryl-CoA from crotonyl-CoA than in the parent strain. The activity of the gene product is evaluated by measuring the activity of the enzyme it catalyzes.
A decrease in gene expression leads to a decrease in the activity of the gene product. Gene expression levels can be measured using quantitative PCR (qPCR) or next-generation sequencing (NGS). Even if a gene's coding region or expression regulatory region is partially mutated, the gene may still be expressed normally. However, even in this case, if the activity of the gene product is 50% or less of that of the parent strain, this constitutes "gene disruption."
Gene disruption can be achieved by mutating (by base deletion, substitution, insertion, addition, or a combination thereof) the coding region or gene expression regulatory region, such as the promoter region, of the gene on the chromosome of a Hydrogenophilus bacterium. Methods for gene disruption are well known, including gene knockout using homologous recombination and phenotype-based screening using random gene mutations introduced using mutagens.
本発明の変異体は、コード領域である上記(a)~(d)の遺伝子の1つ以上が変異したものが好ましい。各コード領域を変異させるには、代表的には、各遺伝子の全領域又は一部領域を欠失させればよい。また、各遺伝子の内部に何らかのヌクレオチド、オリゴヌクレオチド、又はポリヌクレオチドを挿入することで、この遺伝子を破壊することもできる。また、各遺伝子の全領域又は一部領域を他のヌクレオチド、オリゴヌクレオチド、又はポリヌクレオチドに置換することもできる。複数ヌクレオチドの欠損、置換、及び/又は挿入を導入する場合、遺伝子中の1か所に導入してもよく、複数か所に分散して導入してもよい。 The mutant of the present invention preferably has a mutation in one or more of the above-mentioned genes (a) to (d), which are coding regions. Mutation of each coding region typically involves deleting all or part of each gene. Alternatively, a gene can be disrupted by inserting a nucleotide, oligonucleotide, or polynucleotide into the gene. Alternatively, all or part of each gene can be replaced with another nucleotide, oligonucleotide, or polynucleotide. When multiple nucleotide deletions, substitutions, and/or insertions are introduced, they may be introduced at a single location within the gene, or may be distributed across multiple locations.
欠損、置換、又は挿入するヌクレオチド数は3以上が好ましい。また、遺伝子全長の1%以上の数のヌクレオチドを欠損、置換、又は挿入することが好ましい。これにより確実に各遺伝子を破壊することができる。各遺伝子の全長にわたり(即ち、各遺伝子の構成ヌクレオチド数の100%を)欠失又は置換させてもよい。挿入するヌクレオチド数は、100,000個以下とすることができる。 The number of nucleotides to be deleted, substituted, or inserted is preferably 3 or more. It is also preferable to delete, replace, or insert nucleotides that account for 1% or more of the entire length of the gene. This ensures that each gene is disrupted reliably. It is also possible to delete or replace the entire length of each gene (i.e., 100% of the nucleotides constituting each gene). The number of nucleotides to be inserted can be 100,000 or less.
ヒドロゲノフィラス属細菌の上記(a)の遺伝子としては、下記(a1)~(a5)の遺伝子が挙げられる。
(a1) 配列番号1の塩基配列を含む(特に、からなる)DNA
(a2) 配列番号1の塩基配列と90%以上、中でも95%以上、中でも98%以上、中でも99%以上の同一性を有する塩基配列を含み(特に、からなり)、かつ3-ヒドロキシブチリル-CoAデヒドラターゼ活性を有するポリペプチドをコードするDNA
(a3) 配列番号2のアミノ酸配列を含む(特に、からなる)ポリペプチドをコードするDNA
(a4) 配列番号2と90%以上、中でも95%以上、中でも98%以上、中でも99%以上の同一性を有するアミノ酸配列を含み(特に、からなり)、かつ3-ヒドロキシブチリル-CoAデヒドラターゼ活性を有するポリペプチド、をコードするDNA
(a5) 配列番号2のアミノ酸配列において、1~10個、中でも1~5個、中でも1~3個、中でも1個のアミノ酸が欠失、置換、挿入、又は付加されたアミノ酸配列を含み(特に、からなり)、かつ3-ヒドロキシブチリル-CoAデヒドラターゼ活性を有するポリペプチド、をコードするDNA
配列番号1は、ヒドロゲノフィラス サーモルテオラス野生株の遺伝子であるHPTL_0565の塩基配列であり、配列番号2は、ヒドロゲノフィラス サーモルテオラス野生株のHPTL_0565がコードするポリペプチドのアミノ酸配列である。
Examples of the above-mentioned (a) gene of a bacterium of the genus Hydrogenophilus include the following genes (a1) to (a5):
(a1) DNA containing (particularly consisting of) the base sequence of SEQ ID NO: 1
(a2) DNA containing (particularly consisting of) a nucleotide sequence having 90% or more, particularly 95% or more, particularly 98% or more, particularly 99% or more identity to the nucleotide sequence of SEQ ID NO: 1, and encoding a polypeptide having 3-hydroxybutyryl-CoA dehydratase activity.
(a3) DNA encoding a polypeptide comprising (particularly consisting of) the amino acid sequence of SEQ ID NO: 2
(a4) DNA encoding a polypeptide comprising (particularly consisting of) an amino acid sequence having 90% or more, particularly 95% or more, particularly 98% or more, particularly 99% or more identity to SEQ ID NO: 2 and having 3-hydroxybutyryl-CoA dehydratase activity.
(a5) DNA encoding a polypeptide comprising (particularly consisting of) an amino acid sequence in which 1 to 10, preferably 1 to 5, preferably 1 to 3, preferably 1 amino acid in the amino acid sequence of SEQ ID NO: 2 have been deleted, substituted, inserted, or added, and which has 3-hydroxybutyryl-CoA dehydratase activity.
SEQ ID NO: 1 is the nucleotide sequence of HPTL_0565, a gene of the Hydrogenophilus thermorteolus wild strain, and SEQ ID NO: 2 is the amino acid sequence of a polypeptide encoded by HPTL_0565 of the Hydrogenophilus thermorteolus wild strain.
ヒドロゲノフィラス属細菌の上記(b)の遺伝子としては、下記(b1)~(b5)の遺伝子が挙げられる。
(b1) 配列番号3の塩基配列を含む(特に、からなる)DNA
(b2) 配列番号3の塩基配列と90%以上、中でも95%以上、中でも98%以上、中でも99%以上の同一性を有する塩基配列を含み(特に、からなり)、かつエノイルCoAヒドラターゼ活性を有するポリペプチドをコードするDNA
(b3) 配列番号4のアミノ酸配列を含む(特に、からなる)ポリペプチドをコードするDNA
(b4) 配列番号4と90%以上、中でも95%以上、中でも98%以上、中でも99%以上の同一性を有するアミノ酸配列からなり、かつエノイルCoAヒドラターゼ活性を有するポリペプチド、をコードするDNA
(b5) 配列番号4のアミノ酸配列において、1~20個、中でも1~10個、中でも1~5個、中でも1~3個、中でも1個のアミノ酸が欠失、置換、挿入、又は付加されたアミノ酸配列を含み(特に、からなり)、かつエノイルCoAヒドラターゼ活性を有するポリペプチド、をコードするDNA
配列番号3は、ヒドロゲノフィラス サーモルテオラス野生株の遺伝子であるHPTL_1099の塩基配列であり、配列番号4は、ヒドロゲノフィラス サーモルテオラス野生株のHPTL_1099がコードするポリペプチドのアミノ酸配列である。
Examples of the above-mentioned (b) gene of bacteria of the genus Hydrogenophilus include the following genes (b1) to (b5):
(b1) DNA containing (particularly consisting of) the base sequence of SEQ ID NO: 3
(b2) DNA containing (particularly consisting of) a nucleotide sequence having 90% or more, particularly 95% or more, particularly 98% or more, particularly 99% or more identity to the nucleotide sequence of SEQ ID NO: 3, and encoding a polypeptide having enoyl-CoA hydratase activity.
(b3) DNA encoding a polypeptide comprising (particularly consisting of) the amino acid sequence of SEQ ID NO: 4
(b4) DNA encoding a polypeptide consisting of an amino acid sequence having 90% or more, particularly 95% or more, particularly 98% or more, particularly 99% or more identity to SEQ ID NO: 4 and having enoyl-CoA hydratase activity.
(b5) DNA encoding a polypeptide comprising (particularly consisting of) an amino acid sequence in which 1 to 20, preferably 1 to 10, preferably 1 to 5, preferably 1 to 3, preferably 1 amino acid in the amino acid sequence of SEQ ID NO: 4 have been deleted, substituted, inserted, or added, and which has enoyl-CoA hydratase activity.
SEQ ID NO: 3 is the nucleotide sequence of HPTL_1099, a gene of the Hydrogenophilus thermorteolus wild strain, and SEQ ID NO: 4 is the amino acid sequence of a polypeptide encoded by HPTL_1099 of the Hydrogenophilus thermorteolus wild strain.
ヒドロゲノフィラス属細菌の上記(b)の遺伝子としては、下記(b6)~(b10)の遺伝子も挙げられる。
(b6) 配列番号5の塩基配列を含む(特に、からなる)DNA
(b7) 配列番号5の塩基配列と90%以上、中でも95%以上、中でも98%以上、中でも99%以上の同一性を有する塩基配列を含み(特に、からなり)、かつエノイルCoAヒドラターゼ活性を有するポリペプチドをコードするDNA
(b8) 配列番号6のアミノ酸配列を含む(特に、からなる)ポリペプチドをコードするDNA
(b9) 配列番号6と90%以上、中でも95%以上、中でも98%以上、中でも99%以上の同一性を有するアミノ酸配列を含み(特に、からなり)、かつエノイルCoAヒドラターゼ活性を有するポリペプチド、をコードするDNA
(b10) 配列番号6のアミノ酸配列において、1~20個、中でも1~10個、中でも1~5個、中でも1~3個、中でも1個のアミノ酸が欠失、置換、挿入、又は付加されたアミノ酸配列を含み(特に、からなり)、かつエノイルCoAヒドラターゼ活性を有するポリペプチド、をコードするDNA
配列番号5は、ヒドロゲノフィラス サーモルテオラス野生株の遺伝子であるHPTL_1333の塩基配列であり、配列番号6は、ヒドロゲノフィラス サーモルテオラス野生株のHPTL_1333がコードするポリペプチドのアミノ酸配列である。
Examples of the above-mentioned (b) gene of bacteria of the genus Hydrogenophilus also include the following genes (b6) to (b10):
(b6) DNA comprising (particularly consisting of) the base sequence of SEQ ID NO: 5
(b7) DNA comprising (particularly consisting of) a nucleotide sequence having 90% or more, particularly 95% or more, particularly 98% or more, particularly 99% or more identity to the nucleotide sequence of SEQ ID NO: 5, and encoding a polypeptide having enoyl-CoA hydratase activity.
(b8) DNA encoding a polypeptide comprising (particularly consisting of) the amino acid sequence of SEQ ID NO: 6
(b9) DNA encoding a polypeptide comprising (particularly consisting of) an amino acid sequence having 90% or more, particularly 95% or more, particularly 98% or more, particularly 99% or more identity to SEQ ID NO: 6 and having enoyl-CoA hydratase activity.
(b10) DNA encoding a polypeptide comprising (particularly consisting of) an amino acid sequence in which 1 to 20, preferably 1 to 10, preferably 1 to 5, preferably 1 to 3, preferably 1 amino acid in the amino acid sequence of SEQ ID NO: 6 have been deleted, substituted, inserted, or added, and which has enoyl-CoA hydratase activity.
SEQ ID NO: 5 is the nucleotide sequence of HPTL_1333, a gene of the Hydrogenophilus thermorteolus wild strain, and SEQ ID NO: 6 is the amino acid sequence of a polypeptide encoded by HPTL_1333 of the Hydrogenophilus thermorteolus wild strain.
ヒドロゲノフィラス属細菌の上記(c)の遺伝子としては、下記(c1)~(c5)の遺伝子が挙げられる。
(c1) 配列番号7の塩基配列を含む(特に、からなる)DNA
(c2) 配列番号7の塩基配列と90%以上、中でも95%以上、中でも98%以上、中でも99%以上の同一性を有する塩基配列を含み(特に、からなり)、かつ3-ヒドロキシアシル-CoAデヒドロゲナーゼ活性を有するポリペプチドをコードするDNA
(c3) 配列番号8のアミノ酸配列を含む(特に、からなる)ポリペプチドをコードするDNA
(c4) 配列番号8と90%以上、中でも95%以上、中でも98%以上、中でも99%以上の同一性を有するアミノ酸配列を含み(特に、からなり)、かつ3-ヒドロキシアシル-CoAデヒドロゲナーゼ活性を有するポリペプチド、をコードするDNA
(c5) 配列番号8のアミノ酸配列において、1~20個、中でも1~10個、中でも1~5個、中でも1~3個、中でも1個のアミノ酸が欠失、置換、挿入、又は付加されたアミノ酸配列を含み(特に、からなり)、かつ3-ヒドロキシアシル-CoAデヒドロゲナーゼ活性を有するポリペプチド、をコードするDNA
配列番号7は、ヒドロゲノフィラス サーモルテオラス野生株の遺伝子であるHPTL_0624の塩基配列であり、配列番号8は、ヒドロゲノフィラス サーモルテオラス野生株のHPTL_0624がコードするポリペプチドのアミノ酸配列である。
Examples of the above-mentioned (c) gene of a bacterium of the genus Hydrogenophilus include the following genes (c1) to (c5):
(c1) DNA comprising (particularly consisting of) the base sequence of SEQ ID NO: 7
(c2) DNA containing (particularly consisting of) a nucleotide sequence having 90% or more, particularly 95% or more, particularly 98% or more, particularly 99% or more identity to the nucleotide sequence of SEQ ID NO: 7, and encoding a polypeptide having 3-hydroxyacyl-CoA dehydrogenase activity.
(c3) DNA encoding a polypeptide comprising (particularly consisting of) the amino acid sequence of SEQ ID NO: 8
(c4) DNA encoding a polypeptide comprising (particularly consisting of) an amino acid sequence having 90% or more, particularly 95% or more, particularly 98% or more, particularly 99% or more identity to SEQ ID NO: 8 and having 3-hydroxyacyl-CoA dehydrogenase activity.
(c5) DNA encoding a polypeptide comprising (particularly consisting of) an amino acid sequence in which 1 to 20, preferably 1 to 10, preferably 1 to 5, preferably 1 to 3, preferably 1 amino acid in the amino acid sequence of SEQ ID NO: 8 have been deleted, substituted, inserted, or added, and which has 3-hydroxyacyl-CoA dehydrogenase activity.
SEQ ID NO: 7 is the nucleotide sequence of HPTL_0624, a gene of the Hydrogenophilus thermorteolus wild strain, and SEQ ID NO: 8 is the amino acid sequence of the polypeptide encoded by HPTL_0624 of the Hydrogenophilus thermorteolus wild strain.
ヒドロゲノフィラス属細菌の上記(c)の遺伝子としては、下記(c6)~(c10)の遺伝子も挙げられる。
(c6) 配列番号9の塩基配列を含む(特に、からなる)DNA
(c7) 配列番号9の塩基配列と90%以上、中でも95%以上、中でも98%以上、中でも99%以上の同一性を有する塩基配列を含み(特に、からなり)、かつ3-ヒドロキシアシル-CoAデヒドロゲナーゼ活性を有するポリペプチドをコードするDNA
(c8) 配列番号10のアミノ酸配列を含む(特に、からなる)ポリペプチドをコードするDNA
(c9) 配列番号10と90%以上、中でも95%以上、中でも98%以上、中でも99%以上の同一性を有するアミノ酸配列を含み(特に、からなり)、かつ3-ヒドロキシアシル-CoAデヒドロゲナーゼ活性を有するポリペプチド、をコードするDNA
(c10) 配列番号10のアミノ酸配列において、1~70個、中でも1~50個、中でも1~20個、中でも1~10個、中でも1~5個、中でも1~3個、中でも1個のアミノ酸が欠失、置換、挿入、又は付加されたアミノ酸配列を含み(特に、からなり)、かつ3-ヒドロキシアシル-CoAデヒドロゲナーゼ活性を有するポリペプチド、をコードするDNA
配列番号9は、ヒドロゲノフィラス サーモルテオラス野生株の遺伝子であるHPTL_0998の塩基配列であり、配列番号10は、ヒドロゲノフィラス サーモルテオラス野生株のHPTL_0998がコードするポリペプチドのアミノ酸配列である。
Examples of the above-mentioned (c) gene of bacteria of the genus Hydrogenophilus also include the following genes (c6) to (c10):
(c6) DNA comprising (particularly consisting of) the base sequence of SEQ ID NO: 9
(c7) DNA containing (particularly consisting of) a nucleotide sequence having 90% or more, particularly 95% or more, particularly 98% or more, particularly 99% or more identity to the nucleotide sequence of SEQ ID NO: 9, and encoding a polypeptide having 3-hydroxyacyl-CoA dehydrogenase activity.
(c8) DNA encoding a polypeptide comprising (particularly consisting of) the amino acid sequence of SEQ ID NO: 10
(c9) DNA encoding a polypeptide comprising (particularly consisting of) an amino acid sequence having 90% or more, particularly 95% or more, particularly 98% or more, particularly 99% or more identity to SEQ ID NO: 10 and having 3-hydroxyacyl-CoA dehydrogenase activity.
(c10) DNA encoding a polypeptide comprising (particularly consisting of) an amino acid sequence in which 1 to 70, preferably 1 to 50, preferably 1 to 20, preferably 1 to 10, preferably 1 to 5, preferably 1 to 3, preferably 1 amino acid in the amino acid sequence of SEQ ID NO: 10 have been deleted, substituted, inserted, or added, and which has 3-hydroxyacyl-CoA dehydrogenase activity.
SEQ ID NO: 9 is the nucleotide sequence of HPTL_0998, which is a gene of the Hydrogenophilus thermorteolus wild strain, and SEQ ID NO: 10 is the amino acid sequence of the polypeptide encoded by HPTL_0998 of the Hydrogenophilus thermorteolus wild strain.
ヒドロゲノフィラス属細菌の上記(d)の遺伝子としては、下記(d1)~(d5)の遺伝子が挙げられる。
(d1) 配列番号11の塩基配列を含む(特に、からなる)DNA
(d2) 配列番号11の塩基配列と90%以上、中でも95%以上、中でも98%以上、中でも99%以上の同一性を有する塩基配列を含み(特に、からなり)、かつメチルグルタコニル-CoAヒドラターゼ活性を有するポリペプチドをコードするDNA
(d3) 配列番号12のアミノ酸配列を含む(特に、からなる)ポリペプチドをコードするDNA
(d4) 配列番号12と90%以上、中でも95%以上、中でも98%以上、中でも99%以上の同一性を有するアミノ酸配列を含み(特に、からなり)、かつメチルグルタコニル-CoAヒドラターゼ活性を有するポリペプチド、をコードするDNA
(d5) 配列番号12のアミノ酸配列において、1~20個、中でも1~10個、中でも1~5個、中でも1~3個、中でも1個のアミノ酸が欠失、置換、挿入、又は付加されたアミノ酸配列を含み(特に、からなり)、かつメチルグルタコニル-CoAヒドラターゼ活性を有するポリペプチド、をコードするDNA
配列番号11は、ヒドロゲノフィラス サーモルテオラス野生株の遺伝子であるHPTL_0272の塩基配列であり、配列番号12は、ヒドロゲノフィラス サーモルテオラス野生株のHPTL_0272がコードするポリペプチドのアミノ酸配列である。
Examples of the above-mentioned (d) gene of a bacterium of the genus Hydrogenophilus include the following genes (d1) to (d5):
(d1) DNA comprising (particularly consisting of) the base sequence of SEQ ID NO: 11
(d2) DNA containing (particularly consisting of) a nucleotide sequence having 90% or more, particularly 95% or more, particularly 98% or more, particularly 99% or more identity to the nucleotide sequence of SEQ ID NO: 11, and encoding a polypeptide having methylglutaconyl-CoA hydratase activity.
(d3) DNA encoding a polypeptide comprising (particularly consisting of) the amino acid sequence of SEQ ID NO: 12
(d4) DNA encoding a polypeptide comprising (particularly consisting of) an amino acid sequence having 90% or more, particularly 95% or more, particularly 98% or more, particularly 99% or more identity to SEQ ID NO: 12 and having methylglutaconyl-CoA hydratase activity.
(d5) DNA encoding a polypeptide comprising (particularly consisting of) an amino acid sequence in which 1 to 20, preferably 1 to 10, preferably 1 to 5, preferably 1 to 3, preferably 1 amino acid in the amino acid sequence of SEQ ID NO: 12 have been deleted, substituted, inserted, or added, and which has methylglutaconyl-CoA hydratase activity.
SEQ ID NO: 11 is the nucleotide sequence of HPTL_0272, a gene of the Hydrogenophilus thermorteolus wild strain, and SEQ ID NO: 12 is the amino acid sequence of a polypeptide encoded by HPTL_0272 of the Hydrogenophilus thermorteolus wild strain.
本発明において、塩基配列及びアミノ酸配列の同一性は、GENETYX ver.17(GENETYX 株式会社ゼネティックス製)により算出した値である。 In the present invention, the identity of base sequences and amino acid sequences is a value calculated using GENETYX ver. 17 (GENETYX, manufactured by Genetyx Corporation).
被験ポリペプチドが3-ヒドロキシブチリル-CoAデヒドラターゼ活性、エノイルCoAヒドラターゼ活性、3-ヒドロキシアシル-CoAデヒドロゲナーゼ活性、又はメチルグルタコニル-CoAヒドラターゼ活性を有することは、In vitro反応によって、被験ポリペプチドを1mMのクロトニルCoAを基質とし、52℃で10分間反応させ、反応後の溶液を高速液体クロマトグラフィー(HPLC)で分析し、クロトニルCoAの減少で確認する。 Whether a test polypeptide has 3-hydroxybutyryl-CoA dehydratase activity, enoyl-CoA hydratase activity, 3-hydroxyacyl-CoA dehydrogenase activity, or methylglutaconyl-CoA hydratase activity is confirmed by in vitro reaction of the test polypeptide with 1 mM crotonyl-CoA as a substrate at 52°C for 10 minutes, analyzing the reaction solution by high-performance liquid chromatography (HPLC), and observing the decrease in crotonyl-CoA.
ヒドロゲノフィラス属細菌
ヒドロゲノフィラス属細菌としては、ヒドロゲノフィラス サーモルテオラス(Hydrogenophilus thermoluteolus)、ヒドロゲノフィラス ハロラブダス(Hydrogenophilus halorhabdus)、ヒドロゲノフィラス デニトリフィカンス(Hydrogenophilus denitrificans)、ヒドロゲノフィラス ハルシ(Hydrogenophilus hirschii)、ヒドロゲノフィラス アイランディカス(Hydrogenophilus islandicus)、ヒドロゲノフィラス チオオキシダンス(Hydrogenophilus thiooxidans)、ヒドロゲノフィラス属細菌Mar3株(Hydrogenophilus sp. Mar3)、ヒドロゲノフィラス属細菌Z1038株(Hydrogenophilus sp. Z1038)などが挙げられる。中でも、炭酸固定微生物としてトップレベルの生育速度ひいては炭酸固定能力を有する点で、ヒドロゲノフィラス サーモルテオラスが好ましい。
ヒドロゲノフィラス属細菌は地球上のいたる所から簡単に分離できる。ヒドロゲノフィラス サーモルテオラスの好ましい株として、TH-1(NBRC 14978)株が挙げられる。ヒドロゲノフィラス サーモルテオラス TH-1(NBRC 14978)株は、極めて高い生育速度を示す〔Agricultural and Biological Chemistry, 41, 685-690 (1977)〕(1時間で2倍に増殖)。ヒドロゲノフィラス サーモルテオラスNBRC 14978株は、ブダペスト条約の下で国際寄託されており、公に利用可能である。
Examples of Hydrogenophilus bacteria include Hydrogenophilus thermoluteolus, Hydrogenophilus halorhabdus, Hydrogenophilus denitrificans, Hydrogenophilus hirschii, Hydrogenophilus islandicus, Hydrogenophilus thiooxidans, Hydrogenophilus sp. Mar3, and Hydrogenophilus sp. Z1038. Among these, Hydrogenophilus thermoluteolus is preferred because it has the highest growth rate and carbon dioxide fixation ability among carbon dioxide fixation microorganisms.
Hydrogenophilus bacteria can be easily isolated from all over the world. A preferred strain of Hydrogenophilus thermorteolus is the TH-1 (NBRC 14978) strain. The TH-1 (NBRC 14978) strain exhibits an extremely high growth rate (Agricultural and Biological Chemistry, 41, 685-690 (1977)) (doubling in one hour). The NBRC 14978 strain has been deposited internationally under the Budapest Treaty and is publicly available.
ヒドロゲノフィラス属細菌は、自然界から単離された細菌の他、自然界から単離された細菌を遺伝学的に改変した細菌であってもよい。改変は、導入した遺伝子を高度に発現できるようにするなどの目的で行うことができる。このような改変は、例えば、目的物質生成を妨げるゲノム上の遺伝子の破壊や、ヒドロゲノフィラス属細菌中の内在性プラスミドの除去(キュアリング)などにより行うことができる。 Hydrogenophilus bacteria can be bacteria isolated from nature, or bacteria that have been genetically modified from bacteria isolated from nature. Modifications can be carried out for purposes such as enabling high expression of introduced genes. Such modifications can be carried out, for example, by disrupting genes in the genome that prevent the production of target substances, or by removing (curing) endogenous plasmids in Hydrogenophilus bacteria.
本発明のヒドロゲノフィラス属細菌変異体は、ゲノム上に本来有する遺伝子の発現により物質生産させることもできるが、目的物質の生産のため、目的物質の生合成に必要な代謝経路をコードする代謝酵素遺伝子が導入されたものとすることができる。即ち、本発明の変異体は、目的物質の生合成に必要な代謝経路をコードする外来の代謝酵素遺伝子を有するものとすることができる。本発明のヒドロゲノフィラス属細菌変異体は、1種又は2種以上の代謝酵素遺伝子を導入することができ、従って1種又は2種以上の外来の代謝酵素遺伝子を有することができる。このように、本発明のヒドロゲノフィラス属細菌変異体は、クロトニルCoAから目的物質を生成する代謝経路の何れかの工程を触媒する酵素遺伝子を導入するための宿主として用いることができる。
クロトニルCoAの代謝により生成する目的物質又は有用物質としては、クロチルアルコール、ブタジエン、ブタノールなどが挙げられ、クロトニルCoAからこれらの物質を生成する代謝経路の何れかの工程を触媒する酵素遺伝子の1以上を導入することができる。
本発明では、ヒドロゲノフィラス属細菌のゲノム上に存在する内在遺伝子及び宿主ヒドロゲノフィラス属細菌のゲノム上に存在しない異種遺伝子の何れであっても、宿主に導入した遺伝子を「外来遺伝子」と称する。
The Hydrogenophilus bacterium mutant of the present invention can produce a substance by expressing genes inherently contained in its genome, but for the production of a target substance, metabolic enzyme genes encoding a metabolic pathway necessary for the biosynthesis of the target substance can also be introduced. That is, the mutant of the present invention can have an exogenous metabolic enzyme gene encoding a metabolic pathway necessary for the biosynthesis of the target substance. One or more metabolic enzyme genes can be introduced into the Hydrogenophilus bacterium mutant of the present invention, and therefore, the mutant can have one or more exogenous metabolic enzyme genes. In this way, the Hydrogenophilus bacterium mutant of the present invention can be used as a host for introducing an enzyme gene that catalyzes any step in the metabolic pathway that produces a target substance from crotonyl-CoA.
Target or useful substances produced by the metabolism of crotonyl-CoA include crotyl alcohol, butadiene, butanol, etc., and one or more enzyme genes that catalyze any step in the metabolic pathway that produces these substances from crotonyl-CoA can be introduced.
In the present invention, a gene introduced into a host is referred to as a "foreign gene," whether it is an endogenous gene present in the genome of the Hydrogenophilus bacterium or a heterologous gene not present in the genome of the host Hydrogenophilus bacterium.
(2)目的物質の製造方法
本発明は、上記説明した本発明のヒドロゲノフィラス属細菌変異体(クロトニルCoAから目的物質を生成する代謝経路の何れかの工程を触媒する酵素遺伝子を導入している場合及びこのような酵素遺伝子を導入していない場合の両方を含む)を培養する工程を含む、目的物質の製造方法を提供する。この方法は、水素、酸素、及び二酸化炭素を含む混合ガスを供給しながら、無機培地又は有機培地を用いて、本発明の変異体を培養する工程を含む。供給されるガスは、水素、酸素、及び二酸化炭素からなる混合ガスであることが好ましいが、目的物質を効率的に生成できる範囲で異種ガスが混入していてもよい。
(2) Method for Producing a Target Substance The present invention provides a method for producing a target substance, comprising the step of culturing the above-described Hydrogenophilus bacterium mutant of the present invention (both the mutant and the mutant having no enzyme gene introduced therein, which catalyzes any step in the metabolic pathway for producing the target substance from crotonyl-CoA). This method includes the step of culturing the mutant of the present invention in an inorganic or organic medium while supplying a mixed gas containing hydrogen, oxygen, and carbon dioxide. The supplied gas is preferably a mixed gas consisting of hydrogen, oxygen, and carbon dioxide, but other gases may be mixed in as long as the target substance can be efficiently produced.
ヒドロゲノフィラス属細菌は、水素をエネルギー源として、二酸化炭素を唯一の炭素源として生育できるため、特に、炭素源として実質的に二酸化炭素のみを用いて(特に、二酸化炭素のみを用いて)、目的物質を生産することにより、二酸化炭素を効率的に固定できる。よって、本発明の方法において、有機物や炭酸塩などの炭素源を含まない無機培地を用いること、即ち、実質的に二酸化炭素のみを炭素源として(特に、二酸化炭素のみを炭素源として)培養することが好ましい。本発明における「二酸化炭素を唯一の炭素源として用いる」ことは、不可避の量の他の炭素源が混入する場合を包含する。 Hydrogenophilus bacteria can grow using hydrogen as an energy source and carbon dioxide as the sole carbon source, and therefore can efficiently fix carbon dioxide by producing a target substance using essentially only carbon dioxide (especially using only carbon dioxide) as a carbon source. Therefore, in the method of the present invention, it is preferable to use an inorganic medium that does not contain carbon sources such as organic matter or carbonates, i.e., to culture using essentially only carbon dioxide as a carbon source (especially using carbon dioxide as the only carbon source). In the present invention, "using carbon dioxide as the sole carbon source" includes cases where unavoidable amounts of other carbon sources are mixed in.
培養に用いる培地のpHは、6.2~8が好ましく、6.4~7.4がより好ましく、6.6~7がさらにより好ましい。この範囲であれば、菌の生育および混合ガスの培地中への溶解性が高く、目的物質を高い効率で製造できる。
バッチ培養を行う場合、混合ガスを密閉された培養容器に封入して静置培養又は振盪培養することができ、混合ガスの培地中への溶解が向上する点で振盪培養が好ましい。連続培養を行う場合、混合ガスを密閉した培養容器に連続供給しながら振盪培養するか、或いは密閉した培養容器を用いてバブリングにより混合ガスを培地内に導入しながら変異体を培養すればよい。
供給ガス中の水素、酸素、二酸化炭素の容量比(水素:酸素:二酸化炭素)は、1.75~7.5:1:0.25~3が好ましく、5~7.5:1:1~2がより好ましく、6.25~7.5:1:1.5がさらにより好ましい。この範囲であれば、変異体の生育が良好であり、目的物質を効率的に製造できる。
混合ガス又は原料ガスの供給速度は、培地1L当たり、10~60L/時間、好ましくは10~40L/時間、より好ましくは10~20L/時間とすればよい。この範囲であれば、変異体の生育が良好であり、目的物質を効率的に製造できると共に、混合ガスの無駄が抑えられる。
培養温度は、35~55℃が好ましく、37~52℃がより好ましく、50~52℃がさらにより好ましい。この範囲であれば、変異体の生育が良好であり、目的物質を効率的に製造できる。
The pH of the medium used for the culture is preferably 6.2 to 8, more preferably 6.4 to 7.4, and even more preferably 6.6 to 7. Within this range, the growth of the bacteria and the solubility of the mixed gas in the medium are high, and the target substance can be produced with high efficiency.
In the case of batch culture, the mixed gas can be sealed in a sealed culture vessel and cultured by static culture or shaking, with shaking culture being preferred since it improves the dissolution of the mixed gas into the medium. In the case of continuous culture, the mixed gas can be continuously supplied to a sealed culture vessel while the culture is shaken, or the mutant can be cultured in a sealed culture vessel while introducing the mixed gas into the medium by bubbling.
The volume ratio of hydrogen, oxygen, and carbon dioxide in the feed gas (hydrogen:oxygen:carbon dioxide) is preferably 1.75-7.5:1:0.25-3, more preferably 5-7.5:1:1-2, and even more preferably 6.25-7.5:1:1.5. Within these ranges, the growth of the mutant is favorable and the target substance can be efficiently produced.
The supply rate of the mixed gas or raw material gas may be 10 to 60 L/hour, preferably 10 to 40 L/hour, and more preferably 10 to 20 L/hour per L of medium. Within this range, the growth of the mutant is favorable, the target substance can be produced efficiently, and waste of the mixed gas is reduced.
The culture temperature is preferably 35 to 55° C., more preferably 37 to 52° C., and even more preferably 50 to 52° C. Within this range, the mutant grows well and the target substance can be produced efficiently.
上記のようにして培養することにより、培養液中に目的物質が生成される。培養液を回収することにより目的物質を回収できるが、さらに、公知の方法で目的物質を反応液から分離することもできる。そのような公知の方法として、膜分離、蒸留などが挙げられる。 By culturing as described above, the target substance is produced in the culture medium. The target substance can be recovered by collecting the culture medium, but it can also be separated from the reaction solution using known methods. Such known methods include membrane separation and distillation.
次に、本発明を、実施例を参照することにより説明する。本発明の技術的範囲は、以下の実施例によって限定されない。
実施例1:大腸菌で発現させた副反応酵素候補の機能確認
ヒドロゲノフィラス属細菌が有する副反応酵素を特定するために、ヒドロゲノフィラス サーモルテオラスの当該反応を有する可能性があると考えた14種類の酵素の遺伝子(配列番号3、5、7、9、11、12、13-20)をプラスミドpCAMO-6(配列番号21)のNde IとEcoR I制限酵素サイトを利用してクローニングした。各プラスミド上にクローニングした遺伝子配列は、DNAシークエンシングで正しい配列であることを確認した。
副反応の可能性があると考えた14種類の酵素の遺伝子は下記のものである。
HPTL_1099(配列番号3)
HPTL_0565(配列番号1)
HPTL_0624(配列番号7)
HPTL_0998(配列番号9)
HPTL_1333(配列番号5)
HPTL_0272(配列番号11)
HPTL_1429(配列番号13)
HPTL_1650(配列番号14)
HPTL_1427(配列番号15)
HPTL_0993(配列番号16)
HPTL_0471(配列番号17)
HPTL_0239(配列番号18)
HPTL_0472(配列番号19)
HPTL_1001(配列番号20)
The present invention will now be described with reference to examples, but the technical scope of the present invention is not limited to the following examples.
Example 1: Functional verification of candidate side reaction enzymes expressed in E. coli To identify the side reaction enzymes possessed by Hydrogenophilus bacteria, genes for 14 enzymes (SEQ ID NOs: 3, 5, 7, 9, 11, 12, 13-20) thought to be capable of the relevant reaction in Hydrogenophilus thermorteolus were cloned into the plasmid pCAMO-6 (SEQ ID NO: 21) using the Nde I and EcoR I restriction enzyme sites. The gene sequences cloned into each plasmid were confirmed to be correct by DNA sequencing.
The genes for 14 enzymes that are thought to be potential side effects are listed below.
HPTL_1099 (SEQ ID NO: 3)
HPTL_0565 (SEQ ID NO: 1)
HPTL_0624 (SEQ ID NO: 7)
HPTL_0998 (SEQ ID NO: 9)
HPTL_1333 (SEQ ID NO: 5)
HPTL_0272 (SEQ ID NO: 11)
HPTL_1429 (SEQ ID NO: 13)
HPTL_1650 (SEQ ID NO: 14)
HPTL_1427 (SEQ ID NO: 15)
HPTL_0993 (SEQ ID NO: 16)
HPTL_0471 (SEQ ID NO: 17)
HPTL_0239 (SEQ ID NO: 18)
HPTL_0472 (SEQ ID NO: 19)
HPTL_1001 (SEQ ID NO: 20)
上記14種類の酵素遺伝子を挿入した各プラスミドで、大腸菌JM109株を形質転換した。カナマイシン50μg/mLを含むLB寒天培地に生育した各形質転換体コロニーを、カナマイシン50μg/mLを含むLB液体培地5mLが入った試験管にて37℃、一晩振盪培養した。各目的酵素は培養中にpCAMO-6に含まれるtac promoterにより、誘導物質の添加なしで発現する。一晩培養した培養液2mLを遠心分離(4℃、5,000g、10分間)して菌体を回収した。回収した菌体を300μLの100mM Tris-HCl(pH7.5)バッファーに懸濁し、超音波破砕した。各菌体細胞破砕液に、最終濃度が1 mMになるようにクロトニルCoAを添加混合し、52℃で10分間反応させた。反応開始5分後及び10分後に回収した反応液サンプルをHPLCで分析し、クロトニルCoAおよび3-ヒドロキシブチリル-CoAを検出した。空ベクターpCAMO-6を導入した大腸菌JM109株についても同様にしてクロトニルCoA及び3-ハイドロキシブチリルCoAを検出した。 E. coli JM109 strain was transformed with each of the plasmids containing the 14 enzyme genes listed above. Each transformant colony grown on LB agar medium containing 50 μg/mL kanamycin was cultured overnight at 37°C with shaking in a test tube containing 5 mL of LB liquid medium containing 50 μg/mL kanamycin. During culture, each target enzyme is expressed without the addition of an inducer by the tac promoter contained in pCAMO-6. 2 mL of the overnight culture was centrifuged (4°C, 5,000 g, 10 minutes) to recover the bacterial cells. The recovered bacterial cells were suspended in 300 μL of 100 mM Tris-HCl (pH 7.5) buffer and disrupted by ultrasound. Crotonyl-CoA was added to each bacterial cell lysate to a final concentration of 1 mM, mixed, and incubated at 52°C for 10 minutes. Reaction samples collected 5 and 10 minutes after the start of the reaction were analyzed by HPLC to detect crotonyl-CoA and 3-hydroxybutyryl-CoA. Crotonyl-CoA and 3-hydroxybutyryl-CoA were also detected in the E. coli JM109 strain containing the empty vector pCAMO-6.
HPLCのクロマトグラムを図3A、図3Bに示す。図3A、図3Bは5分後と10分後のクロマトグラムを含む。その結果、14種類の候補のうち、HPTL_1099, HPTL_0565, HPTL_0624, HPTL_0998, HPTL_1333、及びHPTL_0272を発現させた菌体細胞破砕液で、空ベクターに比べてクロトニルCoA量が少ないか、又は5分後に比べて10分後にクロトニルCoA量が減少していた。また、HPTL_0565, HPTL_0998, HPTL_1333, HPTL_0272では空ベクターに比べて、3-ヒドロキシブチリル-CoA生成量が多かった。従って、HPTL_1099, HPTL_0565, HPTL_0624, HPTL_0998, HPTL_1333、及びHPTL_0272は、クロトニルCoAから有用物質生成する反応を妨げる副反応を触媒する酵素遺伝子であると考えられた。中でも、HPTL_0565遺伝子を発現させた株が最も大幅にクロトニルCoAを減少させており、最も強い副生反応活性を有していた。 The HPLC chromatograms are shown in Figures 3A and 3B. Figures 3A and 3B include chromatograms taken after 5 and 10 minutes. Among the 14 candidates, the results showed that the bacterial cell lysates expressing HPTL_1099, HPTL_0565, HPTL_0624, HPTL_0998, HPTL_1333, and HPTL_0272 either produced less crotonyl-CoA than the empty vector, or the amount of crotonyl-CoA was lower after 10 minutes than after 5 minutes. Furthermore, HPTL_0565, HPTL_0998, HPTL_1333, and HPTL_0272 produced more 3-hydroxybutyryl-CoA than the empty vector. Therefore, HPTL_1099, HPTL_0565, HPTL_0624, HPTL_0998, HPTL_1333, and HPTL_0272 were thought to be enzyme genes that catalyze side reactions that interfere with the reaction that produces useful substances from crotonyl-CoA. Among them, the strain expressing the HPTL_0565 gene had the greatest reduction in crotonyl-CoA and possessed the strongest side reaction activity.
実施例2:HPTL_0565の遺伝子破壊株の作製
ヒドロゲノフィラス サーモルテオラスのTH-1(NBRC 14978)株の野生株をもとに、実施例1で最も副反応活性が高い結果を得たHPTL_0565の遺伝子破壊株を相同組み換えにより取得した。
Example 2: Preparation of a gene-disrupted strain of HPTL_0565 A gene-disrupted strain of HPTL_0565, which had the highest side reaction activity in Example 1, was obtained by homologous recombination using a wild-type strain of Hydrogenophilus thermorteolus TH-1 (NBRC 14978).
(1)ストレプトマイシン耐性株の取得
ヒドロゲノフィラス サーモルテオラス TH-1株(NBRC 14978)(以下、「TH-1株」ということがある)をA液体培地〔(NH4)2SO4 3.0 g、KH2PO4 1.0 g、K2HPO4 2.0 g、NaCl 0.25 g、FeSO4・7H2O 0.014 g、MgSO4・7H2O 0.5 g、CaCl2 0.03 g、MoO3 4.0 mg、ZnSO4・7H2O 28 mg、CuSO4・5H2O 2.0 mg、H3BO3 4.0 mg、MnSO4・5H2O 4.0 mg、CoCl2・6H2O 4.0 mgを蒸留水1Lに溶解(pH 7.0)〕5mLの入ったガラスバイアルに白金耳を用いて植菌し、H2:O2:CO2=7.5:1:1.5の混合ガスを封入して52℃で振盪培養した。24時間後の培養液をストレプトマイシン 100 μg/mLを含むLB固体培地に播種し、52℃で72時間培養した。
その結果、ストレプトマイシン 100 μg/mLを含むLB固体培地上で3つのコロニーの形成が確認できた。これらのコロニーをストレプトマイシン 100 μg/mLを含むA液体培地5mLの入ったガラスバイアルに白金耳を用いて植菌し、H2:O2:CO2=7.5:1:1.5の混合ガスを封入して52℃で培養した。24時間後に菌の生育が見られたことから、これらの株はTH-1株のストレプトマイシン耐性株であり、そのうちの1つをSR88株と命名した。
なお、水素細菌のストレプトマイシン耐性株は、水素細菌の培養液をストレプトマイシン 10~100 μg/mLを含む固体培地上で培養することにより、一定の比率で出現する。
(1) Obtaining a streptomycin-resistant strain Hydrogenophilus thermorteolus TH-1 strain (NBRC 14978) (hereinafter referred to as "TH-1 strain") was cultured in liquid medium A [( NH4 ) 2SO4 3.0 g, KH2PO4 1.0 g, K2HPO4 2.0 g, NaCl 0.25 g, FeSO4· 7H2O 0.014 g, MgSO4 · 7H2O 0.5 g , CaCl2 0.03 g, MoO3 4.0 mg, ZnSO4 ·7H2O 28 mg, CuSO4 · 5H2O 2.0 mg, H3BO3 4.0 mg, MnSO4 · 5H2O 4.0 mg, CoCl2 · 6H2O 4.0 mg ] . The bacteria were inoculated into a glass vial containing 5 mL of [100 mg dissolved in 1 L of distilled water (pH 7.0)] using a platinum loop, and cultured with shaking at 52°C under a gas mixture of H 2 :O 2 :CO 2 = 7.5:1:1.5. After 24 hours, the culture was inoculated onto LB solid medium containing 100 μg/mL streptomycin and cultured at 52°C for 72 hours.
As a result, the formation of three colonies was confirmed on LB solid medium containing 100 μg/mL streptomycin. These colonies were inoculated using a platinum loop into a glass vial containing 5 mL of liquid medium A containing 100 μg/mL streptomycin, and the mixture was cultured at 52°C under a gas mixture of H 2 :O 2 :CO 2 = 7.5:1:1.5. Since bacterial growth was observed after 24 hours, these strains were streptomycin-resistant strains of the TH-1 strain, and one of them was designated strain SR88.
Streptomycin-resistant strains of hydrogen bacteria emerge at a certain rate when the culture solution of hydrogen bacteria is cultured on a solid medium containing 10 to 100 μg/mL of streptomycin.
(2) マーカーカセット及び発現プラスミドの構築におけるPCR、電気泳動、DNAの回収、及びシームレスクローニング
マーカーカセット及び発現プラスミドの構築での、PCR、電気泳動、DNAの回収、及びシームレスクローニングを行うためのプラスミドベクターpCAMO-6の調製は下記の通り行った。
(2) PCR, electrophoresis, DNA recovery, and seamless cloning in the construction of marker cassettes and expression plasmids
In constructing the marker cassette and expression plasmid, PCR, electrophoresis, DNA recovery, and preparation of the plasmid vector pCAMO-6 for seamless cloning were carried out as follows.
(2-1) PCR、電気泳動、DNAの回収
PCRは、ライフテクノロジーズ社製の「DNAサーマルサイクラー」を用い、反応試薬としてKOD One PCR Master Mix (東洋紡株式会社製)を用いて、常法により行った。その後、生成した反応液を、1%アガロースゲルを用いた電気泳動に供し、必要に応じ適切なDNA断片をゲルからGEL/PCR Purification Mini Kit(FAVORGEN)を用いて回収した。
(2-1) PCR, electrophoresis, and DNA recovery PCR was performed using a Life Technologies DNA Thermal Cycler and KOD One PCR Master Mix (Toyobo Co., Ltd.) as the reaction reagent, according to standard methods. The resulting reaction mixture was then subjected to electrophoresis using a 1% agarose gel, and appropriate DNA fragments were recovered from the gel using a GEL/PCR Purification Mini Kit (FAVORGEN) as needed.
(2-2) シームレスクローニングのためのプラスミドベクターpCAMO-6の調製
シームレスクローニングを行うために、配列番号21のDNAを鋳型として、プラスミドベクターpCAMO-6をPCRにより増幅した。PCRには、以下のプライマーを用いた。
プラスミドベクターpCAMO-6の増幅使用プライマー
(a-1)5’-GAATTCGAGCTCCGTCGACA-3’(配列番号22)
(b-1)5’-ATGCGTTTCTCCTCCAGATC-3’(配列番号23)
電気泳動に供した結果、ベクター遺伝子に相当する約5.2kbpのDNA断片が検出され、ゲルからDNA断片を回収した。
(2-2) Preparation of Plasmid Vector pCAMO-6 for Seamless Cloning To perform seamless cloning , the plasmid vector pCAMO-6 was amplified by PCR using the DNA of SEQ ID NO: 21 as a template. The following primers were used for PCR.
Primer (a-1) used for amplification of the plasmid vector pCAMO-6: 5'-GAATTCGAGCTCCGTCGACA-3' (SEQ ID NO: 22)
(b-1) 5'-ATGCGTTTCTCCTCCAGATC-3' (SEQ ID NO: 23)
As a result of electrophoresis, a DNA fragment of approximately 5.2 kbp corresponding to the vector gene was detected, and the DNA fragment was recovered from the gel.
(2-3) ベクターpCAMO-6のDNA断片と他DNA断片の結合
エシェリヒア コリJM109株から抽出したレコンビナーゼを用いて、上記で合成したベクターpCAMO-6のDNA断片と挿入するDNA断片を互いに結合させた。
得られた反応液で、ヒートショック法により、エシェリヒア コリJM109株を形質転換し、カナマイシン50μg/mLを含むLB培地に塗布し、37℃にて24時間培養した。
(2-3) Ligation of the DNA fragment of the vector pCAMO-6 with another DNA fragment Using recombinase extracted from Escherichia coli JM109, the DNA fragment of the vector pCAMO-6 synthesized above was ligated to the DNA fragment to be inserted.
The resulting reaction mixture was used to transform Escherichia coli JM109 strain by the heat shock method, and the transformed transformant was plated on LB medium containing 50 μg/mL of kanamycin and cultured at 37° C. for 24 hours.
(2-4)プラスミド抽出と遺伝子配列確認
LB培地上の各生育株をカナマイシン50μg/mLを含むLB液体培地5mLの入った試験管に白金耳を用いて植菌し、37℃で振盪培養し、培養液よりプラスミドDNAを抽出した。各プラスミドに挿入した遺伝子の配列は、ユーロフィンジェノミクス株式会社に委託して、Sanger法による解析を行い、データベース上の配列と一致することを確認した。
(2-4) Plasmid extraction and gene sequence confirmation Each strain grown on LB medium was inoculated using a platinum loop into a test tube containing 5 mL of LB liquid medium containing 50 μg/mL of kanamycin, and cultured with shaking at 37°C, and plasmid DNA was extracted from the culture medium. The sequence of the gene inserted into each plasmid was analyzed by the Sanger method at Eurofins Genomics, Inc., and confirmed to match the sequence in the database.
(3)マーカーカセットの構築
(3-1)カウンターセレクションマーカーの調製
TH-1株の野生株(ストレプトマイシン感受性株)から、常法に従い、ゲノムDNAを抽出した。抽出したゲノムDNAを鋳型として用いて、S12リボソームタンパク質をコードする、ストレプトマイシン感受性の原因遺伝子であるrpsL遺伝子を含むDNA断片をPCR法により増幅した。PCRには、以下のプライマーを用いた。
TH-1株の野生型rpsL遺伝子増幅用プライマー
(a-2) 5’-CTGGAGGAGAAACGCATATGCCAACCATCAACCAGTTGGTG-3’(配列番号24)
(b-2) 5’-CGACGGAGCTCGAATTCTTATTTCTTGCCCGCAGCGGC-3’(配列番号25)
なお、プライマー(a-2)とプライマー(b-2)にはベクターpCAMO-6と相同な配列が付加されている。
電気泳動に供した結果、TH-1株の野生株のrpsL遺伝子に相当する約0.4kbpのDNA断片が検出されゲルからDNA断片を回収した。
(3) Construction of marker cassette
(3-1) Preparation of counterselection marker: Genomic DNA was extracted from a wild-type TH-1 strain (a streptomycin-sensitive strain) according to standard methods. Using the extracted genomic DNA as a template, a DNA fragment containing the rpsL gene, which encodes the S12 ribosomal protein and is responsible for streptomycin sensitivity, was amplified by PCR. The following primers were used for PCR:
Primers for amplifying the wild-type rpsL gene of the TH-1 strain
(a-2) 5'-CTGGAGGAGAAACGCATATGCCAACCATCAACCAGTTGGTG-3' (SEQ ID NO: 24)
(b-2) 5'-CGACGGAGCTCGAATTCTTATTTCTTGCCCGCAGCGGC-3' (SEQ ID NO: 25)
Primer (a-2) and primer (b-2) contain sequences homologous to the vector pCAMO-6.
As a result of electrophoresis, a DNA fragment of approximately 0.4 kbp corresponding to the rpsL gene of the wild-type TH-1 strain was detected, and the DNA fragment was recovered from the gel.
ベクターpCAMO-6のDNA断片とrpsLのDNA断片を互いに結合させ、エシェリヒア コリJM109株を形質転換した。その後、プラスミド抽出を行い、rpsL遺伝子の配列を確認した。 The DNA fragment of vector pCAMO-6 and the DNA fragment of rpsL were ligated together and used to transform Escherichia coli strain JM109. Plasmid was then extracted and the sequence of the rpsL gene was confirmed.
rpsL遺伝子が導入されたpCAMO-6を鋳型にtacプロモーター領域を含むrpsL遺伝子を増幅した。
tacプロモーター領域を含むrpsL遺伝子増幅用プライマー
(a-3)5’-CATAACGGTTCTGGCAAATATTC-3’(配列番号26)
(b-3)5’-GCCATATGCGATACTCCTCCTCATTTCTTGCCCGCAGCGGCGCC-3’(配列番号27)
なお、プライマー(b-3)にはブレオマイシン耐性遺伝子との結合に必要な配列が付加されている。
電気泳動に供した結果、tacプロモーター領域を含むrpsL遺伝子に相当する、約0.4kbpのDNA断片が検出され、ゲルからDNA断片を回収した。
The rpsL gene containing the tac promoter region was amplified using pCAMO-6, into which the rpsL gene had been introduced, as a template.
Primer (a-3) for amplifying the rpsL gene containing the tac promoter region: 5'-CATAACGGTTCTGGCAAATATTC-3' (SEQ ID NO: 26)
(b-3) 5'-GCCATATGCGATACTCCTCCTCATTTCTTGCCCGCAGCGGCGCC-3' (SEQ ID NO: 27)
The primer (b-3) contains a sequence required for binding to the bleomycin resistance gene.
As a result of electrophoresis, a DNA fragment of about 0.4 kbp corresponding to the rpsL gene containing the tac promoter region was detected, and the DNA fragment was recovered from the gel.
(3-2)ポジティブセレクションマーカーの調製
当業者に公知の手法を用いて人工的に合成された(部分的にコドンを置き換えた)ストレプトアロテイカス ヒンダスタヌス(Streptoalloteichus hindustanus)のDNAを鋳型として、ブレオマイシン耐性遺伝子配列のDNA断片をPCR法により増幅した。PCRには、以下のプライマーを用いた。
(a-4)5’-GAAATGAGGAGGAGTATCGCATATGGCTAAACTTACTTCTGCTG-3’(配列番号28)
(b-4)5’-TCAATCTTGTTCCTCTGCAACAAAATG-3’(配列番号29)
なお、プライマー(a-4)にはrpsL遺伝子との結合に必要な配列が付加されている。
電気泳動に供した結果、ブレオマイシン耐性遺伝子に相当する約0.4kbpのDNA断片が検出され、ゲルからDNA断片を回収した。
(3-2) Preparation of a positive selection marker: Using artificially synthesized (partially codon-substituted) DNA from Streptoalloteichus hindustanus as a template, a DNA fragment of the bleomycin resistance gene sequence was amplified by PCR using the following primers:
(a-4) 5'-GAAATGAGGAGGAGTATCGCATATGGCTAAACTTACTTCTGCTG-3' (SEQ ID NO: 28)
(b-4) 5'-TCAATCTTGTTCCTCTGCAACAAAATG-3' (SEQ ID NO: 29)
The primer (a-4) contains a sequence necessary for binding to the rpsL gene.
As a result of electrophoresis, a DNA fragment of approximately 0.4 kbp corresponding to the bleomycin resistance gene was detected, and the DNA fragment was recovered from the gel.
(3-3)マーカーカセットの調製
tacプロモーター領域を含むrpsL遺伝子断片とブレオマイシン耐性遺伝子断片を混合し、PCR法により、連結させ増幅した。PCRには、以下のプライマーを用いた。
(a-5)5’-CCAAAGTAAAGGAGAGTAGCACATAACGGTTCTGGCAAATATTC-3’(配列番号30)
(b-5)5’-CGGTGAAGCTCGAAACTCAATCTTGTTCCTCTGCAACAAAATG-3’(配列番号31)
なお、プライマー(a-5)にはHPTL_0565遺伝子の5’側領域との結合に必要な配列が、プライマー(b-5)にはHPTL_0565遺伝子の3’側領域との結合に必要な配列が、それぞれ付加されている。
電気泳動に供した結果、連結したマーカーカセット遺伝子に相当する、約1.0kbpのDNA断片が検出され、ゲルからDNA断片を回収した。
(3-3) Preparation of Marker Cassette The rpsL gene fragment containing the tac promoter region and the bleomycin resistance gene fragment were mixed, ligated, and amplified by PCR. The following primers were used for PCR.
(a-5) 5'-CCAAAGTAAAGGAGAGTAGCACATAACGGTTCTGGCAAATATTC-3' (SEQ ID NO: 30)
(b-5) 5'-CGGTGAAGCTCGAAACTCAATCTTGTTCCTCTGCAACAAAATG-3' (SEQ ID NO: 31)
Primer (a-5) contains a sequence required for binding to the 5' region of the HPTL_0565 gene, and primer (b-5) contains a sequence required for binding to the 3' region of the HPTL_0565 gene.
As a result of electrophoresis, a DNA fragment of about 1.0 kbp corresponding to the ligated marker cassette gene was detected, and the DNA fragment was recovered from the gel.
(4)宿主のHPTL_0565遺伝子の破壊
(4-1)HPTL_0565遺伝子破壊用DNAの構築
TH-1株の野生株のゲノムDNAを鋳型として用いて、HPTL_0565遺伝子の5’側領域(HPTL_0565遺伝子の5’末端領域と上流領域を含む)に相当するDNA断片及び、HPTL_0565の3’側領域(0565遺伝子の3’末端領域と下流領域を含む)に相当するDNA断片をPCR法により増幅した。PCRには、以下のプライマーを用いた。
HPTL_0565遺伝子の5’側領域増幅用プライマー
(a-6)5’-CTTCTCCCGAGCCCAATCGCGGG-3’(配列番号32)
(b-6)5’-CAGAATATTTGCCAGAACCGTTATGTTAAGCCAAGATATCGGCTTCCGAAACGG-3’(配列番号33)
なお、プライマー(b-6)にはマーカーカセットとの結合に必要な配列が付加されている。
HPTL_0565遺伝子の3’側領域増幅用プライマー
(a-7)5’-CATTTTGTTGCAGAGGAACAAGATTGAATCTCGACGCGGAGTTCGCG-3’(配列番号34)
(b-7)5’-GTGGTTGCTCTGCTTGCGCC-3’(配列番号35)
なお、プライマー(a-7)にはマーカーカセットとの結合に必要な配列が付加されている。
電気泳動に供した結果、HPTL_0565遺伝子の5’側領域及び3’側領域に相当する約1.7kbp及び約1.3kbpのDNA断片がそれぞれ検出され、ゲルからDNA断片を回収した。
(4) Disruption of the host HPTL_0565 gene
(4-1) Construction of DNA for disrupting the HPTL_0565 gene Using the genomic DNA of the wild-type TH-1 strain as a template, a DNA fragment corresponding to the 5' region of the HPTL_0565 gene (including the 5'-terminal region and upstream region of the HPTL_0565 gene) and a DNA fragment corresponding to the 3' region of HPTL_0565 (including the 3'-terminal region and downstream region of the 0565 gene) were amplified by PCR. The following primers were used for PCR:
Primer (a-6) for amplifying the 5' region of the HPTL_0565 gene: 5'-CTTCTCCCGAGCCCAATCGCGGG-3' (SEQ ID NO: 32)
(b-6) 5'-CAGAATATTTGCCAGAACCGTTATGTTAAGCCAAGATATCGGCTTCCGAAACGG-3' (SEQ ID NO: 33)
The primer (b-6) contains a sequence required for binding to the marker cassette.
Primer (a-7) for amplifying the 3' region of the HPTL_0565 gene: 5'-CATTTTGTTGCAGAGGAACAAGATTGAATCTCGACGCGGAGTTCGCG-3' (SEQ ID NO: 34)
(b-7) 5'-GTGGTTGCTCTGCTTGCGCC-3' (SEQ ID NO: 35)
The primer (a-7) contains a sequence required for binding to the marker cassette.
As a result of electrophoresis, DNA fragments of approximately 1.7 kbp and approximately 1.3 kbp corresponding to the 5' and 3' regions of the HPTL_0565 gene were detected, respectively, and the DNA fragments were recovered from the gel.
このようにして調製したHPTL_0565遺伝子の5’側領域のDNA断片、3’側領域のDNA断片、及び(3-3)で調製したマーカーカセットを混合し、PCR法により連結させ増幅した。PCRには、以下のプライマーを用いた。
(a-6)5’-CTTCTCCCGAGCCCAATCGCGGG-3’(配列番号32)
(b-7)5’-GTGGTTGCTCTGCTTGCGCC-3’(配列番号35)
電気泳動に供した結果、5’側領域のDNA断片と3’側領域のDNA断片とマーカーカセットDNA断片を含むDNA断片に相当する、約4.2kbpのDNA断片が検出され、ゲルからDNA断片を回収した。このDNA断片はHPTL_0565遺伝子ラベリング用DNAである。
The DNA fragments from the 5' and 3' regions of the HPTL_0565 gene prepared in this way and the marker cassette prepared in (3-3) were mixed and ligated by PCR, followed by amplification. The following primers were used for PCR.
(a-6) 5'-CTTCTCCCGAGCCCAATCGCGGG-3' (SEQ ID NO: 32)
(b-7) 5'-GTGGTTGCTCTGCTTGCGCC-3' (SEQ ID NO: 35)
Electrophoresis revealed a DNA fragment of approximately 4.2 kbp, corresponding to a DNA fragment containing the 5'-region DNA fragment, the 3'-region DNA fragment, and the marker cassette DNA fragment. This DNA fragment was recovered from the gel and used to label the HPTL_0565 gene.
(4-2)ストレプトマイシン耐性株のHPTL_0565遺伝子のラベリング(ポジティブセレクション)
(4-1)で調製したHPTL_0565遺伝子ラベリング用DNAで、電気パルス法(エレクトロポレーション法)により、TH-1株のストレプトマイシン耐性SR88株を形質転換し、ブレオマイシン系抗生物質であるゼオシン 50 μg/mLを含むLB培地に塗布し、52℃にて48時間培養した。
LB培地上の各生育株をブレオマイシン系抗生物質ゼオシン(商品名) 50 μg/mL含むLB培地にそれぞれ再ストリークし、52℃にて24時間培養した。
その結果得られた、ゼオシン耐性の株のゲノムDNAを鋳型として、HPTL_0565遺伝子を含むDNA領域をPCR法により増幅した。PCRには、以下のプライマーを用いた。(a-6)と(b-7)のプライマーの組み合わせを用いてPCRを行えば、HPTL_0565遺伝子がマーカーカセットで置換される場合、約4.2kbpのDNA領域が増幅する。
(a-6)5’-CTTCTCCCGAGCCCAATCGCGGG-3’(配列番号32)
(b-7)5’-GTGGTTGCTCTGCTTGCGCC-3’(配列番号35)
電気泳動に供した結果、HPTL_0565遺伝子がマーカーカセットで置換された配列に相当する約4.2kbpのDNA断片が検出された。この株ではHPTL_0565遺伝子がHPTL_0565遺伝子ラベリング用DNAで置換されることで破壊されていることが分かった。
なお、ここでは、マーカーカセットを脱落させるカウンターセレクションは行わなかった。
マーカーカセットの構築からHPTL_0565遺伝子の破壊までの操作手順を図6A及び図6Bに示す。
(4-2) Labeling of the HPTL_0565 gene in streptomycin-resistant strains (positive selection)
The streptomycin-resistant SR88 strain of the TH-1 strain was transformed with the DNA for labeling the HPTL_0565 gene prepared in (4-1) by electroporation, and the transformed strain was plated on LB medium containing 50 μg/mL of Zeocin, a bleomycin antibiotic, and cultured at 52°C for 48 hours.
Each strain grown on the LB medium was restreaked on an LB medium containing 50 μg/mL of the bleomycin antibiotic Zeocin (trade name), and cultured at 52° C. for 24 hours.
Using the resulting genomic DNA of the Zeocin-resistant strain as a template, the DNA region containing the HPTL_0565 gene was amplified by PCR. The following primers were used for PCR. When PCR was performed using a combination of primers (a-6) and (b-7), a DNA region of approximately 4.2 kbp was amplified if the HPTL_0565 gene was replaced with the marker cassette.
(a-6) 5'-CTTCTCCCGAGCCCAATCGCGGG-3' (SEQ ID NO: 32)
(b-7) 5'-GTGGTTGCTCTGCTTGCGCC-3' (SEQ ID NO: 35)
Electrophoresis detected a 4.2-kbp DNA fragment corresponding to the sequence in which the HPTL_0565 gene had been replaced with the marker cassette, indicating that the HPTL_0565 gene in this strain had been disrupted by replacement with the HPTL_0565 gene labeling DNA.
Here, counter-selection to remove the marker cassette was not performed.
The procedure from construction of the marker cassette to disruption of the HPTL_0565 gene is shown in Figures 6A and 6B.
実施例3:HPTL_0565遺伝子破壊株の副生反応能力の低下確認 No.1
野生株とHPTL_0565遺伝子破壊株をA液体培地 5mLの入った試験管に白金耳を用いて植菌し、試験管に、H2:O2:CO2=7.5:1:1.5の混合ガスを封入して52℃で24時間、振盪培養した。このようにして培養された培養液2mLから、遠心分離(4℃、5,000g、10分間)により菌体を回収した。各菌体を300μLの100mM Tris-HCl (pH 7.5)に懸濁し、超音波で菌体細胞を破砕した。
Example 3: Confirmation of the reduction in by-product reaction ability of the HPTL_0565 gene-disrupted strain No. 1
The wild-type strain and the HPTL_0565 gene disruptant were inoculated into 5 mL of liquid medium A in a test tube using a platinum loop. The tube was then filled with a gas mixture of H 2 :O 2 :CO 2 = 7.5:1:1.5 and cultured with shaking at 52°C for 24 hours. Bacterial cells were harvested from 2 mL of the culture by centrifugation (4°C, 5,000 g, 10 minutes). Each cell was suspended in 300 μL of 100 mM Tris-HCl (pH 7.5) and disrupted by sonication.
各菌体細胞破砕液に、反応基質としてクロトニルCoAを最終濃度(反応当初の反応液中濃度)が1 mMになるように添加混合し、52℃で反応を開始した。反応開始後、1分、2分、3分、5分、10分、15分、及び30分後に50μLずつ反応液をサンプリングした。各時に取得したサンプルをHPLCで分析し、クロトニルCoAを検出した。また同時に3-ヒドロキシブチリル-CoAも検出できる。
その結果、野生株サンプルでは反応に供した1mMのクロトニルCoAが急速に消費され、1分間の反応で、検出されたクロトニルCoAは、0.1 mM以下にまで減少した。反応開始10分後にはクロトニルCoAは検出限界以下にまで減少した。同時に、クロトニルCoAの減少に伴って、3-ヒドロキシブチリル-CoAが生成した。生成した3-ヒドロキシブチリル-CoAはさらに代謝された(図4、野生株)。この結果から、野生株ではクロトニルCoAから3-ヒドロキシブチリル-CoAの方向への反応が急速に行われたことが分かる。
一方、HPTL_0565破壊株サンプルでは、時間の経過に伴って反応に供した1mMのクロトニルCoAの減少が見られたが、1分間の反応で40%程度の減少に留まり、即ち0.6mM程度残存しており、30分間の反応後でも約0.2 mMのクロトニルCoAが残存した。クロトニルCoAから3-ヒドロキシブチリル-CoAの生成が検出されたが、3-ヒドロキシブチリル-CoAの代謝は野生株と比較すると遅かった。HPTL_0565破壊株サンプルでの3-ヒドロキシブチリル-CoAの代謝(減少)は、クロトニルCoAの減少と同様に遅かった。(図4、HPTL_0565遺伝子破壊株)。
菌体破砕液とクロトニルCoAとの反応は、菌体内でのクロトニルCoAの代謝を疑似したものである。上述の結果から、野生株では急速なクロトニルCoAの減少が生じるため、クロトニルCoAの生成と蓄積は殆ど生じないと考えられる。これに対して、HPTL_0565破壊株ではクロトニルCoAの減少能力が大きく減衰しており、クロトニルCoAの生成および蓄積が促進されており、従って、クロトニル-CoAからの有用物質生成に供し得ることが示された。
Crotonyl-CoA was added as a reaction substrate to each bacterial cell lysate to a final concentration of 1 mM (the initial concentration in the reaction solution), and the reaction was initiated at 52°C. 50 μL of the reaction solution was sampled at 1, 2, 3, 5, 10, 15, and 30 minutes after the start of the reaction. The samples taken at each time point were analyzed by HPLC to detect crotonyl-CoA. 3-Hydroxybutyryl-CoA was also detected.
As a result, in the wild-type strain sample, 1 mM crotonyl-CoA used in the reaction was rapidly consumed, and the detected crotonyl-CoA decreased to less than 0.1 mM after 1 minute of reaction. 10 minutes after the start of the reaction, crotonyl-CoA decreased to below the detection limit. Simultaneously, 3-hydroxybutyryl-CoA was produced in association with the decrease in crotonyl-CoA. The produced 3-hydroxybutyryl-CoA was further metabolized (Figure 4, wild-type strain). These results indicate that the reaction from crotonyl-CoA to 3-hydroxybutyryl-CoA occurred rapidly in the wild-type strain.
In contrast, in the HPTL_0565 disruptant sample, the 1 mM crotonyl-CoA used in the reaction decreased over time, but the decrease was only about 40% after 1 minute of reaction, leaving approximately 0.6 mM. Even after 30 minutes of reaction, approximately 0.2 mM crotonyl-CoA remained. The production of 3-hydroxybutyryl-CoA from crotonyl-CoA was detected, but the metabolism of 3-hydroxybutyryl-CoA was slower than in the wild-type strain. The metabolism (decrease) of 3-hydroxybutyryl-CoA in the HPTL_0565 disruptant sample was as slow as the decrease in crotonyl-CoA (Figure 4, HPTL_0565 gene disruptant).
The reaction of the cell lysate with crotonyl-CoA simulates the metabolism of crotonyl-CoA within the cell. The above results suggest that the wild-type strain rapidly reduces crotonyl-CoA, resulting in little production or accumulation of crotonyl-CoA. In contrast, the HPTL_0565 disruptant significantly attenuated the ability to reduce crotonyl-CoA, promoting its production and accumulation. Therefore, it was demonstrated that crotonyl-CoA can be used to produce useful substances.
実施例4:HPTL_0565遺伝子破壊株の副生反応能力の低下確認 No.2
実施例3と同様のサンプルを用いて、反応基質を3-ヒドロキシブチリル-CoAに変更した他は実施例3と同様にして経時的にHPLCでクロトニルCoAと3-ヒドロキシブチリル-CoAを検出した。本実施例の目的は、反応系に添加した1 mMの3-ヒドロキシブチリル-CoAから、ヒドロゲノフィラス サーモルテオラスの菌体破砕液中に存在する内在酵素によってヒドロキシブチリル-CoAクロトニルCoAを生成させ、その検出量を野生株とHPTL_0565遺伝子破壊株で比較することによってHPTL_0565遺伝子破壊によるクロトニルCoAの生成量(供給量)向上への効果を検証することにある。基質が3-ヒドロキシブチリル-CoAである点で、実施例3に比べてより自然状態に近い状態での評価である。
その結果、野生株及びHPTL_0565遺伝子破壊株のいずれの菌体細胞破砕液を用いた反応液からも3-ヒドロキシブチリル-CoAは30分後にはほぼ消失した。また、両菌株共に内在酵素によってクロトニルCoAを生成することも検出された。反応開始1分後に検出されたクロトニルCoA量を、野生株とHPTL_0565破壊株のHPLCクロマトグラフのピーク面積の比較により比較すると、HPTL_0565破壊株で検出されたクロトニルCoA量は、野生株に比べて約4倍程度多く、HPTL_0565遺伝子破壊によって、クロトニルCoAの生成量を向上させることができることが確認された(図5)。
Example 4: Confirmation of the reduction in by-product reaction ability of the HPTL_0565 gene-disrupted strain No. 2
Using the same sample as in Example 3, crotonyl-CoA and 3-hydroxybutyryl-CoA were detected over time by HPLC in the same manner as in Example 3, except that the reaction substrate was changed to 3-hydroxybutyryl-CoA. The purpose of this example was to produce hydroxybutyryl-CoA and crotonyl-CoA from 1 mM 3-hydroxybutyryl-CoA added to the reaction system using endogenous enzymes present in the cell lysate of Hydrogenophilus thermorteolus, and to compare the detected amounts between the wild-type strain and the HPTL_0565 gene-disrupted strain to verify the effect of HPTL_0565 gene disruption on improving the production (supply) of crotonyl-CoA. Because the substrate was 3-hydroxybutyryl-CoA, this example was evaluated under conditions closer to the natural state than in Example 3.
As a result, 3-hydroxybutyryl-CoA almost disappeared after 30 minutes from the reaction mixtures using cell lysates of both the wild-type strain and the HPTL_0565 gene-disrupted strain. Crotonyl-CoA production by endogenous enzymes was also detected in both strains. The amount of crotonyl-CoA detected 1 minute after the start of the reaction was compared by HPLC chromatographic peak area between the wild-type strain and the HPTL_0565-disrupted strain. The amount of crotonyl-CoA detected in the HPTL_0565-disrupted strain was approximately four times higher than that in the wild-type strain, confirming that HPTL_0565 gene disruption can increase the amount of crotonyl-CoA produced (Figure 5).
配列番号1~21を以下に示す。
本発明のヒドロゲノフィラス属細菌変異体は、二酸化炭素の増加による地球温暖化問題を解決しながら、クロトニルCoAを経由して生成するクロチルアルコール、ブタジエン、ブタノールなどの有用物質を高効率で製造するのに使用することができ、プラスチック、ゴム、繊維、ポリマー、バイオ燃料などの化成品製造の需要に応えることができる。 The Hydrogenophilus bacterial mutant of the present invention can be used to efficiently produce useful substances such as crotyl alcohol, butadiene, and butanol, which are produced via crotonyl-CoA, while also solving the problem of global warming caused by increased carbon dioxide, thereby meeting demand for the production of chemical products such as plastics, rubber, fibers, polymers, and biofuels.
Claims (11)
(a) 3-ヒドロキシブチリル-CoAデヒドラターゼ活性を有するポリペプチドをコードする遺伝子
(b) エノイルCoAヒドラターゼ活性を有するポリペプチドをコードする遺伝子
(c) 3-ヒドロキシアシル-CoAデヒドロゲナーゼ活性を有するポリペプチドをコードする遺伝子
(d) メチルグルコタコニル-CoAヒドラターゼ活性を有するポリペプチドをコードする遺伝子 A Hydrogenophilus bacterium mutant in which one or more of the following enzyme genes (a) to (d) present on the chromosome of the Hydrogenophilus bacterium, which catalyze any reaction in the pathway for producing 3-hydroxybutyryl-CoA from crotonyl-CoA, are disrupted:
(a) A gene encoding a polypeptide having 3-hydroxybutyryl-CoA dehydratase activity
(b) a gene encoding a polypeptide having enoyl-CoA hydratase activity
(c) a gene encoding a polypeptide having 3-hydroxyacyl-CoA dehydrogenase activity
(d) a gene encoding a polypeptide having methylglucoconyl-CoA hydratase activity
(a1) 配列番号1の塩基配列を含むDNA
(a2) 配列番号1の塩基配列と90%以上の同一性を有する塩基配列を含み、かつ3-ヒドロキシブチリル-CoAデヒドラターゼ活性を有するポリペプチドをコードするDNA
(a3) 配列番号2のアミノ酸配列を含むポリペプチドをコードするDNA
(a4) 配列番号2と90%以上の同一性を有するアミノ酸配列を含み、かつ3-ヒドロキシブチリル-CoAデヒドラターゼ活性を有するポリペプチド、をコードするDNA
(a5) 配列番号2のアミノ酸配列において、1~10個のアミノ酸が欠失、置換、挿入、又は付加されたアミノ酸配列を含み、かつ3-ヒドロキシブチリル-CoAデヒドラターゼ活性を有するポリペプチド、をコードするDNA The mutant according to claim 1, wherein the gene (a) includes any one of the following genes (a1) to (a5):
(a1) DNA containing the base sequence of SEQ ID NO: 1
(a2) DNA containing a nucleotide sequence having 90% or more identity with the nucleotide sequence of SEQ ID NO: 1 and encoding a polypeptide having 3-hydroxybutyryl-CoA dehydratase activity
(a3) DNA encoding a polypeptide comprising the amino acid sequence of SEQ ID NO: 2
(a4) DNA encoding a polypeptide comprising an amino acid sequence having 90% or more identity to SEQ ID NO: 2 and having 3-hydroxybutyryl-CoA dehydratase activity.
(a5) DNA encoding a polypeptide comprising an amino acid sequence in which 1 to 10 amino acids are deleted, substituted, inserted, or added in the amino acid sequence of SEQ ID NO: 2 and having 3-hydroxybutyryl-CoA dehydratase activity.
(b1) 配列番号3の塩基配列を含むDNA
(b2) 配列番号3の塩基配列と90%以上の同一性を有する塩基配列を含み、かつエノイルCoAヒドラターゼ活性を有するポリペプチドをコードするDNA
(b3) 配列番号4のアミノ酸配列を含むポリペプチドをコードするDNA
(b4) 配列番号4と90%以上の同一性を有するアミノ酸配列を含み、かつエノイルCoAヒドラターゼ活性を有するポリペプチド、をコードするDNA
(b5) 配列番号4のアミノ酸配列において、1~20個のアミノ酸が欠失、置換、挿入、又は付加されたアミノ酸配列を含み、かつエノイルCoAヒドラターゼ活性を有するポリペプチド、をコードするDNA The mutant according to claim 1 or 2, wherein the gene (b) includes any one of the following genes (b1) to (b5):
(b1) DNA containing the base sequence of SEQ ID NO: 3
(b2) DNA containing a nucleotide sequence having 90% or more identity with the nucleotide sequence of SEQ ID NO: 3 and encoding a polypeptide having enoyl-CoA hydratase activity
(b3) DNA encoding a polypeptide comprising the amino acid sequence of SEQ ID NO: 4
(b4) DNA encoding a polypeptide comprising an amino acid sequence having 90% or more identity to SEQ ID NO: 4 and having enoyl-CoA hydratase activity.
(b5) DNA encoding a polypeptide comprising an amino acid sequence in which 1 to 20 amino acids are deleted, substituted, inserted, or added in the amino acid sequence of SEQ ID NO: 4 and having enoyl-CoA hydratase activity.
(b6) 配列番号5の塩基配列を含むDNA
(b7) 配列番号5の塩基配列と90%以上の同一性を有する塩基配列を含み、かつエノイルCoAヒドラターゼ活性を有するポリペプチドをコードするDNA
(b8) 配列番号6のアミノ酸配列を含むポリペプチドをコードするDNA
(b9) 配列番号6と90%以上の同一性を有するアミノ酸配列を含み、かつエノイルCoAヒドラターゼ活性を有するポリペプチド、をコードするDNA
(b10) 配列番号6のアミノ酸配列において、1~20個のアミノ酸が欠失、置換、挿入、又は付加されたアミノ酸配列を含み、かつエノイルCoAヒドラターゼ活性を有するポリペプチド、をコードするDNA The mutant according to any one of claims 1 to 3, wherein the gene (b) includes any one of the genes (b6) to (b10) below.
(b6) DNA containing the base sequence of SEQ ID NO: 5
(b7) DNA encoding a polypeptide having enoyl-CoA hydratase activity and containing a nucleotide sequence having 90% or more identity with the nucleotide sequence of SEQ ID NO: 5.
(b8) DNA encoding a polypeptide comprising the amino acid sequence of SEQ ID NO: 6
(b9) DNA encoding a polypeptide comprising an amino acid sequence having 90% or more identity to SEQ ID NO: 6 and having enoyl-CoA hydratase activity.
(b10) DNA encoding a polypeptide comprising an amino acid sequence in which 1 to 20 amino acids are deleted, substituted, inserted, or added in the amino acid sequence of SEQ ID NO: 6 and having enoyl-CoA hydratase activity.
(c1) 配列番号7の塩基配列を含むDNA
(c2) 配列番号7の塩基配列と90%以上の同一性を有する塩基配列を含み、かつ3-ヒドロキシアシル-CoAデヒドロゲナーゼ活性を有するポリペプチドをコードするDNA
(c3) 配列番号8のアミノ酸配列を含むポリペプチドをコードするDNA
(c4) 配列番号8と90%以上の同一性を有するアミノ酸配列を含み、かつ3-ヒドロキシアシル-CoAデヒドロゲナーゼ活性を有するポリペプチド、をコードするDNA
(c5) 配列番号8のアミノ酸配列において、1~20個のアミノ酸が欠失、置換、挿入、又は付加されたアミノ酸配列を含み、かつ3-ヒドロキシアシル-CoAデヒドロゲナーゼ活性を有するポリペプチド、をコードするDNA The mutant according to any one of claims 1 to 4, wherein the gene (c) includes any one of the genes (c1) to (c5) below.
(c1) DNA containing the base sequence of SEQ ID NO: 7
(c2) DNA containing a nucleotide sequence having 90% or more identity with the nucleotide sequence of SEQ ID NO: 7 and encoding a polypeptide having 3-hydroxyacyl-CoA dehydrogenase activity
(c3) DNA encoding a polypeptide comprising the amino acid sequence of SEQ ID NO: 8
(c4) DNA encoding a polypeptide comprising an amino acid sequence having 90% or more identity to SEQ ID NO: 8 and having 3-hydroxyacyl-CoA dehydrogenase activity.
(c5) DNA encoding a polypeptide comprising an amino acid sequence of SEQ ID NO: 8 in which 1 to 20 amino acids are deleted, substituted, inserted, or added, and having 3-hydroxyacyl-CoA dehydrogenase activity.
(c6) 配列番号9の塩基配列を含むDNA
(c7) 配列番号9の塩基配列と90%以上の同一性を有する塩基配列を含み、かつ3-ヒドロキシアシル-CoAデヒドロゲナーゼ活性を有するポリペプチドをコードするDNA
(c8) 配列番号10のアミノ酸配列を含むポリペプチドをコードするDNA
(c9) 配列番号10と90%以上の同一性を有するアミノ酸配列を含み、かつ3-ヒドロキシアシル-CoAデヒドロゲナーゼ活性を有するポリペプチド、をコードするDNA
(c10) 配列番号10のアミノ酸配列において、1~70個のアミノ酸が欠失、置換、挿入、又は付加されたアミノ酸配列を含み、かつ3-ヒドロキシアシル-CoAデヒドロゲナーゼ活性を有するポリペプチド、をコードするDNA The mutant according to any one of claims 1 to 5, wherein the gene (c) includes any one of the genes (c6) to (c10) below.
(c6) DNA containing the base sequence of SEQ ID NO: 9
(c7) DNA containing a nucleotide sequence having 90% or more identity with the nucleotide sequence of SEQ ID NO: 9 and encoding a polypeptide having 3-hydroxyacyl-CoA dehydrogenase activity
(c8) DNA encoding a polypeptide comprising the amino acid sequence of SEQ ID NO: 10
(c9) DNA encoding a polypeptide comprising an amino acid sequence having 90% or more identity to SEQ ID NO: 10 and having 3-hydroxyacyl-CoA dehydrogenase activity.
(c10) DNA encoding a polypeptide comprising an amino acid sequence in which 1 to 70 amino acids are deleted, substituted, inserted, or added in the amino acid sequence of SEQ ID NO: 10, and having 3-hydroxyacyl-CoA dehydrogenase activity.
(d1) 配列番号11の塩基配列を含むDNA
(d2) 配列番号11の塩基配列と90%以上の同一性を有する塩基配列を含み、かつメチルグルコタコニル-CoAヒドラターゼ活性を有するポリペプチドをコードするDNA
(d3) 配列番号12のアミノ酸配列を含むポリペプチドをコードするDNA
(d4) 配列番号12と90%以上の同一性を有するアミノ酸配列を含み、かつメチルグルコタコニル-CoAヒドラターゼ活性を有するポリペプチド、をコードするDNA
(d5) 配列番号12のアミノ酸配列において、1~20個のアミノ酸が欠失、置換、挿入、又は付加されたアミノ酸配列を含み、かつメチルグルコタコニル-CoAヒドラターゼ活性を有するポリペプチド、をコードするDNA The mutant according to any one of claims 1 to 6, wherein the gene (d) includes any one of the genes (d1) to (d5) below.
(d1) DNA containing the base sequence of SEQ ID NO: 11
(d2) DNA containing a nucleotide sequence having 90% or more identity with the nucleotide sequence of SEQ ID NO: 11 and encoding a polypeptide having methylglucosaconyl-CoA hydratase activity
(d3) DNA encoding a polypeptide comprising the amino acid sequence of SEQ ID NO: 12
(d4) DNA encoding a polypeptide comprising an amino acid sequence having 90% or more identity with SEQ ID NO: 12 and having methylglucosaconyl-CoA hydratase activity.
(d5) DNA encoding a polypeptide comprising an amino acid sequence in which 1 to 20 amino acids are deleted, substituted, inserted, or added in the amino acid sequence of SEQ ID NO: 12 and having methylglucosaconyl-CoA hydratase activity.
A method for producing a target substance, comprising the step of culturing the mutant according to claim 9.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024065052 | 2024-04-14 | ||
| JP2024-065052 | 2024-04-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2025220580A1 true WO2025220580A1 (en) | 2025-10-23 |
Family
ID=97403402
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP2025/014249 Pending WO2025220580A1 (en) | 2024-04-14 | 2025-04-09 | Hydrogenophilus bacterium mutant having improved crotonyl-coa production capability |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2025220580A1 (en) |
-
2025
- 2025-04-09 WO PCT/JP2025/014249 patent/WO2025220580A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11098307B2 (en) | Compositions and methods for rapid and dynamic flux control using synthetic metabolic valves | |
| JP7304859B2 (en) | Microorganisms and methods for bioproduction of ethylene glycol | |
| CN108779429B (en) | Functional expression of monooxygenases and methods of use | |
| JP6603658B2 (en) | Microorganisms and methods for the production of fatty acids and fatty acid derivatives | |
| CN113840909A (en) | Fermentative production of 2-phenylethyl alcohol from gaseous substrates | |
| WO2009049274A2 (en) | Microorganism engineered to produce isopropanol | |
| EP2102327A2 (en) | Engineered microorganisms for producing n-butanol and related methods | |
| KR20100124332A (en) | Polypeptide having glyoxalase iii activity, polynucleotide encoding the same and uses thereof | |
| US8637283B2 (en) | Production of hydrocarbons in microorganisms | |
| JP2017534268A (en) | Modified microorganisms and methods for the production of useful products | |
| WO2025220580A1 (en) | Hydrogenophilus bacterium mutant having improved crotonyl-coa production capability | |
| KR102690858B1 (en) | A recombinant microorganism capable of growing solely on CO2 and formic acid and a method of producing useful materials using the same | |
| EP4617361A1 (en) | 4-hydroxybenzoic acid-producing transformant of bacterium belonging to genus hydrogenophilus | |
| JP7761892B2 (en) | Transformants of Hydrogenophilus sp. producing crotyl alcohol | |
| WO2025062876A1 (en) | Butanol-generating bacterium transformant of genus hydrogenophilus | |
| US12297480B2 (en) | Methods for producing designer esters and assessing alcohol acyltransferase specificity for ester biosynthesis | |
| WO2025142753A1 (en) | Crotonaldehyde-crotyl alcohol dehydrogenase mutant | |
| WO2025220434A1 (en) | Biotin-auxotrophic hydrogen-oxidizing bacterium mutant | |
| US12098168B2 (en) | XylR mutant for improved xylose utilization or improved co-utilization of glucose and xylose preliminary | |
| KR102120995B1 (en) | Transformed methanotrophs for producing 4-Hydroxybutyric acid and uses thereof | |
| WO2025142411A1 (en) | Hydrogenophilus bacterium transformant capable of producing cis, cis-muconic acid or catechol | |
| WO2025134868A1 (en) | Aliphatic alcohol-producing transformant of bacterium belonging to genus hydrogenophilus | |
| WO2018005934A1 (en) | Biological conversion of syngas to liquid chemicals | |
| BR122024008827A2 (en) | GENETICALLY MODIFIED MICROORGANISM |